a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Erasmus MC Institute of Health Policy and Management Activities Report 2007-2008
a
institute of Health Policy and Management Activities Report 2007-2008
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
institute of Health Policy and Management Activities Report 2007-2008
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Contents
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
4 Foreword by prof. Wilfried Notten, Chairman 6 Research theme 1: Competition and regulation in health care 7 Good research is essential for successful managed competition in health care Interview with prof. Wynand van de Ven 8 Research theme 2: Quality and efficiency in health care 9 Value is what counts Interview with prof. Frans Rutten and Maureen Rutten-van Mölken, Associate Professor 10 Research theme 3: Health care management
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
18 Education: Master of Science in Health Care Management by Kees van Wijk, Assistant Professor 19 Post Academic Education: Erasmus CMDz by prof. Pauline Meurs, Director of Erasmus CMDz 19 Academy for Medical Specialists by Pieter Wijsma, Director of Academy MS 20 Always in search of a challenge Interview with former student Igna Bonfrer 22 Management affairs by Marieke Veenstra, Manager 24 Facts & Figures 25 Academic staff
11 Getting better all the time Interview with Anna Nieboer, Associate Professor 12 Faster Better: improvement programme and action study Introduced by Anne Marie Weggelaar, Researcher and Teun Zuiderent-Jerak, Assistant Professor
26 PhD graduates & Inaugural lecture 27 Academic publications 2007 38 Academic publications 2008 48 Colophon
14 Education: In perpetual motion by prof. Roland Bal 16 Education: Bachelor Health Policy and Management by Isabelle Fabbricotti, Assistant Professor 17 Education: Master of Science in Health Economics, Policy & Law by prof. Martin Buijsen
Explanation of photography Apart from portrait photographs, this Activities Report contains interior shots of our new quarters. At page 22 Marieke Veenstra tells more about the new setting.
3
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Foreword ó by prof. Wilfried Notten, Chairman
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
In quite a few respects, the institute of Health Policy and Management (iBMG) reached important milestones in the period 2007-2008; indicative of its rapid progression. If only for the fact that our institute moved to new quarters whose presence and ambience are incomparably better than those in the old situation. But of course we can boast of other and certainly also more drastic developments. In this regard, I must not leave unmentioned that these would not have been possible without the enthusiasm and commitment of all our staff, the helpful cooperation with numerous partners in health care – within Erasmus University Rotterdam but also beyond, both nationally and internationally – and not least the ever growing inflow of students opting for our educational programmes. iBMG is greatly indebted to prof. Frans Rutten in particular, for his years-long dedication as chairman of iBMG and whose position I have taken over on October 1«», 2007. Under his leadership our institute was successful in building a strong reputation. The (health) care sector is the domain that is the focus of iBMG’s research and educational programmes. The political and social developments in the Netherlands in the past few years no doubt are having and will have far-reaching consequences for this sector. Solid scientific underpinning of proposed reforms in the national health care system as a direct result of these developments is a prerequisite – 4
both in the preparatory phase and in the assessment after implementation. The issues may be so complex, however, that underpinning must meet specific conditions. For one thing, it would seem essential to apply a multidisciplinary approach, involving lawyers, business administrators, economists, physicians, etcetera. And then, iBMG’s research should be characterised by innovativeness and applicationorientedness, crucial notions to obtain easily manageable solutions, also in situations where solutions apparently are not directly obvious. Using a multidisciplinary approach both in our research and education, we stand out from the more discipline-oriented faculties in Erasmus University. With its broad knowledge base and a solid network structure of collaborations iBMG is positioned close to the care practice. A typical example is the Care Logistics Expertise Centre that started its activities in 2008. Seeing that the health care domain is so comprehensive, iBMG in spite of its broad expertise needed to focus on select research themes. In 2008, external auditing and intensive communal discussion with the researchers in iBMG led to the selection of three themes as research spearheads in the coming years, i.e.: 1. Market regulation and system reform 2. Quality and effectiveness in health care 3. Management of health care organisations
In 2007 a research innovation budget was made available to stimulate high-quality and innovative studies on these three institute-wide themes, thus further expanding our research reputation. The innovation budget comes on top of the financing on the basis of scientific output, such as publications and PhD-theses. Regarding the scientific output, the number of scientific publications over a series of years is still increasing. Over the report period 16 PhD-theses and one inaugural lecture were published. Furthermore, a wide range of workshops, symposia and conferences, national and international, were held on the initiative of our institute, including the International Conference on Human Rights and Biomedicine and the Annual Meeting of the Society for Social Studies of Science (in association with the European Association for the Study of Science and Technology). Worth mentioning is the fact that four economists listed in the 2008 Elsevier magazine top 40 are health economists in iBMG. In the next years we will first of all give priority to publishing our research findings in internationally renowned, peerreviewed journals. That is, without shutting our eyes to the social importance of good information provision to the care sector in the Netherlands. iBMG’s research efforts indeed fill a social need, as would appear, for example, from the fact that by now more than 50% is funded externally. Apart from ZonMw, government agencies as well as health insurers and pharmaceutical companies are important funding organisations.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Also in the field of education progress has been impressive. Student numbers are still increasing by some 15% yearly. In part, this is due to the growing demand of executives with knowledge and experience on policy, organisation and management issues in health care. In addition, the high quality of our programmes is recognised. It’s not for nothing that our bachelor’s programme in 2008 again occupied the first position in the Elsevier national listing. Our educational programmes are not limited to initial education. In the period reported here, the iBMG-affiliated Erasmus CMDz offered a wide range of highly sophisticated, post academic educational- and training programmes to non-medical trained executives in health care. In addition, anticipating on similar educational needs for executives with a medical specialist background, iBMG together with the Dutch Order of Medical Specialists and VVAA – a service organisation for (para)medics – established the Academy for Medical Specialists. The growth in student numbers but also the increasing interest of external parties to contract out research to iBMG, puts more and more pressure on the current staff complement and thus stimulates rapid growth of the number of vacancies. Filling these vacancies is not easy. This is why one of our biggest challenges now is recruiting suitable new staff. By the close of 2008, iBMG’s staff complement had risen from fewer than 140 early 2007 to over 170 employees. In the report period we have welcomed eight new professorial appointments at iBMG.
With ambition and commitment
As explained above, iBMG boasts of a broad, multidisciplinary knowledge base, one that is strongly oriented at the practice of health care. The first-rate reputation that iBMG managed to establish is certainly due, in part, to the close partnership with Erasmus MC, of which iBMG is an administrative unit (till January 2010). On the other hand we see intensifying collaboration with the other Erasmus University faculties and institutes. Erasmus University Rotterdam has nationally and internationally an excellent reputation in economics and business administration, among other things. It goes without saying that this expertise – where useful – may benefit our research and education in the health care area. In this light, joint professorial chairs have been or will be established as a means to structurally shape the collaborations with the other faculties in Erasmus University. Realising that we are developing into an intermediary institute in a network with the other faculties, the directors of Erasmus MC and Erasmus University have decided to reinstate iBMG’s
organisational position in Erasmus University as from 2010. As a matter of course, the partnership with Erasmus MC will remain of essential importance in the future. In summary: the years 2007 and 2008, again, were hectic years for the world of health care. With great ambition and commitment the researchers in iBMG tackled many problems and challenges that presented themselves. This report presents a choice selection of their efforts. I wish you a pleasant reading experience.
5
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Theme 1:
Competition and regulation in health care a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
The research on this theme is carried out by the iBMG groups Health Care Governance, Health Insurance, Health Economics, and Health Law and concerns the following topics: Care system ó Changing modes of governance in health care (Helderman, Van der Grinten, Zuiderent-Jerak, Bal): How can we understand system reform within the hybrid, multi-layered governance arrangements that characterize the health care sectors? How are infrastructures built to accommodate this change and how do these affect health care work? ó Position of managers of health care providers (Grit, Stoopendaal, Van der Scheer, Meurs): With the system reforms in the health care sectors, how are managers adjusting their roles both internally and externally to accommodate entrepreneurship on the health care market? How is their relation with the health care professions changing? ó Science-policy relations in health care (Bekkers, Van Egmond, Van der Grinten, De Bont, Bal): Looking at both the functioning of science advisory organisations (CPB, RIVM, SCP) and the working of specific instruments (Health Impact Assessment, databases), how can we understand science-policy relations, and what are the effects of current institutionalisations of this relation on the quality of policymaking? ó Justice and solidarity in health care (Buijsen): What do ‘justice’ and ‘solidarity’ mean in the context of health care, seen from the human rights perspective? ó Post mortem organ donation (Buijsen): To what extent are proposed (financial) incentives to reduce waiting lists in accor6
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
dance with international law? To what extent is the introduction of an opting out system in the Netherlands in accordance with international law? Insurance Market ó Risk equalization among insurers (Van Vliet, Van de Ven, Stam, Van Kleef): Insurers are compensated for the risk profile of their insured to increase the affordability of individual health insurance in a competitive insurance market. How can this be best done and what risk factors should enter the risk equalization formula? How can we prevent risk selection by insurers? What can we learn from international experience? ó Competition and competition policy in health care and health insurance markets (Schut, Varkevisser): This programme investigates the structure, conduct and performance of health care markets and the role of government regulation and competition policy. ó Cost sharing by consumers/patients (Van Kleef, Van Vliet, Van de Ven): What are the effects of different forms of cost sharing on health care use? How to deal with the interaction between voluntary deductibles and risk equalization among insurers? ó The use of model agreements in health care purchasing (Den Exter): What are problematic aspects of the use of standardized contracts in purchasing from the point of view of competition law? ó Health care purchasing by insurers (Boonen, Eijkenaar, Van der Geest, Laske): How to channel insured consumers to preferred providers of care? How to pay providers for good performance? ó Supplementary health insurance and group insurance (Schut): Are these types of
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
insurance effective tools for risk selection by insurers? Does supplementary health insurance reduce consumer mobility because chronically ill people fear to be rejected by new insurers? ó Equity in health care use in European countries (Van Doorslaer): What are the roles of private health insurance and geographic disparities in health care supply for equitable health care use? How can we appropriately adjust for health needs? Patient’s perspective ó Consumer choice and switching behaviour in the health care and health insurance markets (Schut): This programme investigates stated and revealed preferences of different types of consumers for different health care providers and health insurers; an important research question is whether health insurers are able to channel consumers to specific preferred providers. ó Formulating the patient’s perspective in health care (Trappenburg, Adams, Van der Kraan): What role do patients play in health care reform and how is the government stimulating patient involvement in health care practice and policy? ó Equal treatment and access to health care (Buijsen): How do market forces affect our understanding of equal treatment in health care and to what extent does it amount to violations of human rights law? ó Unilateral termination of treatment contracts by the health care provider for non medical reasons (Buijsen): Is it in accordance with the law to terminate contracts because of (inter alia) non payment?
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Professor Wynand van de Ven is head of iBMG’s Health Insurance section. We asked him to tell about his major research interest – and the model of managed competition in particular. Dutch health care is undergoing transition to a managed competition model. Why is fundamental research so important? The Netherlands is the first country in the world that is implementing the managed competition model in health care. In theory this is an elegant model, but it’s hard to implement in practice and knowledge about some fundamental issues is lacking. The implementation of the Health Insurance Act in 2006 was a major achievement, as it created a system of universal affordable health insurance. The key question now is whether insurers will become cost-conscious purchasers of care on behalf of their insured consumers. What are the key areas of future research? First, we need a better risk equalization scheme. Such a scheme provides insurers with financial compensation for their high-risk enrolees based upon their risk characteristics. The current prospective scheme shows flaws, and insurers, therefore, retrospectively receive cost-based compensations. This practice is also thought to reduce the incentives for risk selection. At the same time, however, it also reduces the insurers’ incentive to become cost-conscious purchasers of care. The preferred solution to avoid this tradeoff between efficiency and selection is having a good ex-ante risk equalization scheme. Second, we need fundamental knowledge on two issues: How can insurers pay providers of care for good performance, and how can insurers effectively channel their insured patients to well-performing providers of care. In this regard, crucial questions to be answered are the following: what is good performance, how can we measure performance, and how can
Key challenge: will insurers become cost-conscious purchasers of care?
Interview with prof. Wynand van de Ven
Good research is essential for successful managed competition in health care a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
we effectively let the public know about it? Third, if we want a competitive health care market, we cannot do without an effective competition policy. Such policy reduces the risk of cartels and abuse of dominant position. Again we need to answer some fundamental research questions first. For example, how to define the relevant product market and the relevant geographical market of providers of care (e.g. hospitals)? Fourth, we need to find more effective forms of cost-sharing. The current forms of deductibles are ineffective for chronically ill and elderly people, as they know with
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
certainty that each year they will exceed the deductible amount. All in all, we would do well to set up good multidisciplinary research to solve those fundamental issues and achieve successful managed competition in health care.
7
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Theme 2:
Quality and efficiency in health care a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
The research in this theme is carried out by the iBMG groups Health Care Governance, Health Care Management, Health Economics, and Health Law and concerns the following topics:
ó Equity in economic evaluations (Brouwer, Bleichrodt, Rutten, Stolk): The elicitation and use of equity weights in economic evaluations from a societal perspective.
Methodology and application of economic evaluation ó Cost-effectiveness analysis of health care programmes (Al, Attema, Brouwer, Hakkaart, Koopmanschap, Redekop, Rutten, Rutten-van Mölken, Stolk, Uyl-de Groot): Methodology and practical applications. ó Utility measurement in economic evaluation of health care (Attema, Bleichrodt, Brouwer, Stolk, Van Exel): Studies investigating the elicitation of quality of life weights and development and validation of other utility-based outcome measures.
Basic health care package and guidelines ó Pharmaceutical policy (De Bont, Koopmanschap, Rutten, Bal): How can valuebased reimbursement systems be best organised and how can implementation of resulting decisions be promoted? ó Incorporating economic evidence in practice guidelines (Brouwer, Buijsen, Hakkaart, Rutten, Rutten-van Mölken, Uyl-de Groot): Policy and implementation. ó Reliability of information on the Internet (Adams, Bal, Berg, De Bont): How are patients using medical information from the Internet and how reliable is health
a
a
a
a
a
a
care information practically managed both by patients and by (non) governmental initiatives? Outcomes research: (cost-)effectiveness of (medical) technologies in daily practice ó Studies on the cost-effectiveness of health technologies (emphasis on expensive hospital drugs) in actual practice. (Herings, Rutten, Uyl-de Groot) ó Studies into differences in health, health care use and accessibility between native Dutch and ethnic minority patients; cross-cultural validity of measurement instruments to assess health status. (Agyemang, Denktas, Foets) ó Informal care: Studying informal care, its impact on carers and care recipients; respite care. (Brouwer, Koopmanschap, Van Exel) ó Use of information technologies in health care. (Aarts, Bal, de Bont) ó Faster Better: studies on workflow and patient safety issues in the hospital. (Bal, Van Wijngaarden, Zuiderent-Jerak) Health and income ó Economic studies in developing countries (Baltussen, Dror, Niessen, Rutten, Uyl-de Groot): Cost-effectiveness studies, burden-of-illness studies, and health insurance in developing countries. ó Equity in the financing and delivery of health care in developing countries (Van Doorslaer, O’Donnell): Progressivity, poverty impact, financial protection and benefit incidence analysis. ó Income, health and work across the life cycle (Van Doorslaer, Van Ourti, Koolman): trends in income and health inequality in Europe. ó Economics of health behaviour and public health. (Brouwer, Van Exel)
8
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Professor Frans Rutten is head of iBMG’s Health Economics section. Maureen Ruttenvan Mölken is associate professor at iBMG’s health economics section and vice-director of the institute for Medical Technology Assessment (iMTA). Significant research area The past 20 years have seen great progress in economic evaluation – or health technology assessment (HTA). This is now by far the largest research area within health economics. Not only has there been more activity and have methods considerably improved, the studies have also gained a firm place in policy and practice. For instance, cost-effectiveness studies of new innovative medicines have become mandatory for reimbursement in a majority of OECD-countries. iMTA has seen similar progress: currently more than 40 staff members are involved in scientific work and policy advice. Various submissions for reimbursement of major innovative drugs have been supported by iMTA. We have also given recommendations on various aspects of the new health insurance package in the Netherlands, including the conditional reimbursement policy regarding expensive hospital drugs. Do you expect an even more prominent role of economic evaluation in health policy? Indeed, there is a potential for a more prominent role in areas other than decision-making on public health programmes and reimbursement of medicines. The Dutch authorities aim to give HTA a bigger role in the entire cure and care sector but so far did not yet come up with a clear plan on how to proceed. A first prerequisite in our view is further developing of the methodology of economic evaluation. Therefore we have initiated new research on widening the concept of benefit to capture aspects of wellbeing beyond health, for example quality of life of people close to the patient. We also study methods for better evaluation of comprehensive, multi-
Interview with prof. Frans Rutten and Maureen Rutten-van Mölken
Value is what counts a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
disciplinary, integrated care programmes for chronically ill patients. In this regard, we are also conducting discrete choice experiments that should uncover preferences regarding delivery and organization of care. What else is new in economic evaluation? Promising new areas are outcomes research, value of information analysis and indirect effects. Health authorities now demand that value for money is demonstrated in the actual health care setting rather than in a controlled experiment (the latter is often a poor predictor of the former). Real life outcomes research, headed by Carin Uyl, director of iMTA, poses new challenges regarding data collection, analytical techniques to correct for bias and evidence synthesis. Value of information analysis is a relatively new technique to quantify the value of addi-
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
tional research performed in order to reduce decision uncertainty. The outcomes could well be of use in policy-making on conditional reimbursement. Finally, many interventions in health care appear to have important effects in other areas (e.g. youth intervention programmes impact on schooling) and we must search for new methods to quantify these effects.
9
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Theme 3:
Health care management a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
The research on this theme is carried out by the iBMG group Health Care Management and concerns the following topics: Business economics & HRM Starting off market function in health care (Van Ineveld, Rutten) ó Planning and control under the new Dutch DRG-system. (Zuurbier) ó The service care chain. (Van Wijk, Van Dijk, Paauwe) ó HRM and performance. (Paauwe, Van Wijk, Veld, Boon) ó
Integrated health care management & logistics ó Care pathways and logistics control (Vissers, de Vries): Projects in the Rotterdam Eye Hospital, treatment pathways in the Mental Health Care (GGZ), Jeroen
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Bosch Hospital, Catharina Hospital Eindhoven. ó Efficiency improvement in the OR by reducing variability. (Vissers, de Vries, Stepaniak, Tweesteden Hospital) ó Integrated bed- and staff planning on different control levels. (Vissers, de Vries, Berrevoets, UMC Radboud) ó PRACTISE, evaluation of Breakthrough collaborative on thrombolytic care in acute stroke. (Huijsman, Niesen, Van Wijngaarden) ó Integrated delivery systems in the care for the elderly. (Fabbricotti, Huijsman, Meurs) ó Disease management (Nieboer, Lemmens, Van de Wetering, Huijsman): Evaluation of programmes for COPD, neuropathic pain and 22 ZonMw practice projects
Quality and safety ó Evaluation of Care for Better, the Dutch programme for long-term care improvement. (Nieboer, Strating, Zuiderent-Jerak, Stoopendaal, Slaghuis, Makai, Van Loon, Van Ellinkhuizen, Bal) ó Evaluation of a large-scale quality improvement programme for the transition to adult care of young people with chronic conditions. (Nieboer, Strating, Sonneveld, Roebroeck, Van Staa) ó Developing guidelines for mental health care from a patient’s perspective. (Goossensen) ó Building quality report cards for different health care sectors. (Groenewoud, Huijsman, Kreuger) ó Use of information technologies in health care work (de Mul, Aarts, Bal, De Bont): How can we understand the implementation of IT in health care work as sociotechnical changes affecting interprofessional relations, both within and between health care providers? How do these technologies affect the flow of health care work and quality and safety of health care? ó Faster Better (Bal, Zuiderent-Jerak, Verhulst, Van Wijngaarden, Stoffer, Van den Berg): Together with the CBO quality institute and the Order of Medical Specialists, iBMG participates in the Faster Better (pillar 3) programme that advises Dutch hospitals on workflow and patient safety issues. Marketing, acquisition and strategy ó The motives and characteristics of care consumers with a personal care budget. (Oostrik, Huijsman)
10
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Anna Nieboer is associate professor and headed iBMG’s section on Health Care Management and Organization from April 2007 to January 2009. We asked her to describe the research programme and to point out key areas of future research. What is the importance of the research? To start with, our research focuses at improving internal operations management and innovative processes in health care organisations via integrated care management, logistics, quality management and human resource management. Good management is gaining importance because the system reforms challenge health care institutions to become more enterprising. And then, competition forces them to perform as best as possible. But still, the media frequently report on hospitals or nursing homes where things have gone wrong, business-wise. So it would seem that health care institutions need more insight into their own operations in terms of quality, effectiveness and efficiency. Quality in this sense is a wide concept – encompassing goals and performance related to care practices, professionalism, organisational logistics and social aspects. Our research findings, we feel, are quite useful to optimize an organisation’s governance structure, performance and operations management. We are notably interested in the question how health care organisations will be able to meet the increasing demands of patients or clients, seeing that at the same time they are under social pressure to keep costs within bounds. To answer this question we need to know how effective care delivery is and what the options are to reorganise care. Once they set up and manage to control their internal operations management satisfactorily, health care organisations will be able to answer for the results in terms of quality, effectiveness and added value for the client and other relevant stakeholders. This can
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Meeting increasing demands, while keeping costs within bounds is a major challenge for health care organisations
Interview with Anna Nieboer
Getting better all the time a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
only be achieved, however, by having wellsupervised, motivated and qualified staff. What are the key areas of future research? There are various exciting developments in our field. For example, further scientific evolvement of the logistics approach is expected to lead to great benefits. Our expertise in this area has been concentrated in the Care Logistics Expertise Centre, a collaboration with Erasmus MC and the Erasmus School of Economics (ESE). And then, there are important unanswered questions in human resource management. Think of the consequences of the health care system changes for employees, the ways in which effective teams can contribute to better care provision, and the effects of human resource management on the performance of
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
health care organisations. Other questions concern the economic underpinning and accountability of activities at different organizational levels. With the government stepping back and the introduction of market function and performance-related reimbursement on care process level, there is greater need for health care organisations to pursue an active financial policy. Finally, there remain important questions regarding quality management. Sustainable improvement in chronic care is feasible. But only after it has become clear why new methods will work. We are evaluating large-scale quality improvement programmes such as Zorg voor Beter (Care for Better). Evaluation gives insight into (potential) results and provides a basis for recommendations on how to sustain and disseminate them. 11
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Introduced by Anne Marie Weggelaar and Teun Zuiderent-Jerak
Faster Better: improvement programme and action study a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
In the years 2007 and 2008 iBMG participated in the improvement programme Faster Better pillar 3 (Sneller Beter). Faster referred to health care being available soon after it is needed. Better referred to care that is safe, effective and patient-centred. To achieve this, the wide dissemination of current knowledge and good practical examples through several projects was needed. New innovation methods were tried on a large scale and further developed. The Netherlands Organisation for Health Research and Development ZonMw subsidised Faster Better. A consortium consisting of iBMG, the Dutch Order of Medical Specialists and the Dutch Institute for Healthcare CBO was responsible for the programme. iBMG provided advisors to the 12
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
hospitals, as well as project leaders and performed data management. Teun Zuiderent-Jerak (assistant professor) en Anne Marie Weggelaar (researcher) fill us in about the programme. “From 2003 through 2008 24 hospitals participated. Three groups of eight hospitals were created. Each group set up project-teams, which worked on improvements in logistics, safety, patient participation and professional quality. The general purpose of Faster Better was: attaining striking performance improvements in 20% of the hospitals in four years’ time on the priority areas patient logistics and patient safety. At the same time this would give the hospitals some leverage for the internal dissemination of results and broad application of developed competences”.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Faster Better was a quality collaborative. Øvretveit (2002) has defined this approach as the bringing together of groups of professionals from different health care institutions with the aim to improve a quality aspect of service delivery in a structured manner. Departing from proven methods in the field involved, the groups learned about quality improvement methods and methods of change in a series of meetings. ‘Learning’ is a central concept here. Weggelaar and other iBMG researchers studied the way in which the learning system in the Faster Better was functioning. They looked at what the participants learned and how the learning-system was designed. They concluded that more attention was paid to technical aspects rather than social aspects. Still, the project team-members rate social aspects such as having meetings, exerting influence and motivating people as very important for the smooth running of the improvement projects. For that matter, they themselves reported they were lacking the necessary skills. In addition the study showed that the team members displayed two dominant learning styles, i.e. ‘discovery’ and ‘participation’. The way in which the meetings were conducted did not fit in well with these learning styles as these predominantly focused on transferring knowledge and copying the art. Right into the middle of the Faster Better programme the Health Insurance Act came info force. This resulted in quite a few initiatives to introduce market function in health care. Zuiderent-Jerak studied the extent to which reorganised care processes could achieve that market regulation did not only concern costs but also quality improvement. The findings were positive but could not be explained by the introduced market mechanisms. More plausible explaining factors were the observed long-term relations between insurers and care providers as well as the belief that markets would lead to innovation. On the grounds of this study, Zuiderent-Jerak was awarded the Nicholas Mullins Award from the Society for Social Studies of Science.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
13
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
iBMG is continuously improving its educational programmes
Education: In perpetual motion a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
ó by prof. Roland Bal Our educational activities have again worked out well in the past period. Once more we saw higher student numbers, up to 150 in the bachelor Health Policy and Management, 115 in the Master of Science in Health Care Management (Zoma), 55 in the international Master of Science in Health Economics, Policy & Law (HEPL) and 120 in the preparatory programme. iBMG thus has built a strong foundation for a full-grown educational organisation. Moreover, all this was associated with good performance. For example, in 2007 and 2008 the education provided by iBMG was the winner in the Elsevier magazine poll. And for two consecutive years Zoma students were awarded the thesis prize from the Nether14
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
lands Association of Directors in Health Care (NVZD). In addition, the EUR-wide interim evaluation of education sketched a positive picture of the education offered by iBMG. In particular the commitment of lecturers and the efficacy of the educational policy were identified as constructive items. The evaluation committee – chaired by Tom van der Grinten – nevertheless made some recommendations for further improvement; e.g. more attention to international orientation and implementing a cyclic quality assessment system to replace the present system. Furthermore, the educational organisation needs strengthening in view of the strong growth of the programmes, the committee concludes. All recommendations have meanwhile resulted in action or new policy. For one, quality assessment has been made more
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
‘cyclical’ by creating course folders containing the various (quantitative and qualitative) evaluations and the improvement actions devised by the course coordinators. As from the next academic year the evaluations will be digitalized, which makes it easier to generate management information. In addition, the lecturer training policy will be tightened by introducing tailor-made programmes for the various educational roles. An ‘education handbook’ is being prepared, aimed at throwing light on the educational organisation. Furthermore, in the past few years the RISBO institute has assisted in detailing the teaching objectives and in better targeting of the education to ‘academic competences’ – both for the bachelor and the HEPL master. Finally, the international orientation has been widened by signing an agreement on student exchange with Bocconi University in Milan. Also, we have created more opportunities for bachelor students to take part in the curriculum courses abroad. In the future more partnerships with universities abroad will be established. The year 2008 was the year in which the EUR minors system was launched. Thirdyear bachelor students from all EUR-faculties were offered a choice from some fifty ‘broadening’ minors. A great many iBMGstudents indeed opted for minors, e.g. those offered by Public Administration, Business Administration and Psychology. Conversely, the two minors offered by iBMG (one on health care problems in big cities, in cooperation with the Erasmus MC department of Public Health, and one on integral health care management) attracted many students from other faculties. In connection with the introduction of minors the entire third bachelor year was thoroughly restyled, e.g. by remodelling the courses on Change & Renewal and Health Insurance & Health Care System. Besides, we did quite some work on the other bachelor years and the masters as well. The second-year courses on Equity Problems and Integral Health Care were drastically
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
renewed, notably with regard to better integration of the various contributing disciplines. The HEPL master was extended with a new elective on international pharmaceutical policy. In order to achieve more efficient flow of HBO-students a new variant of the preparatory programme was developed, which as from the academic year 2009-2010 is offered next to the current preparatory programme. The new ‘hook up variant’ largely consists of bachelor courses, with several new courses added, and can be completed in a year fulltime education. Fitting in with this scenario, cooperation with the HBO-institutions in Rotterdam was strengthened. Programmes are being prepared that allow for HBO-students with relevant pre-training to move on unhindered by thresholds. This would imply that the HBO-programmes must pay more attention to academic skills in particular. Apart from the minor on health care problems in big cities, cooperation with Erasmus MC was also intensified in other educational fields. Two minors, Health Ethics and Quality and Safety in Clinical Care, are developed jointly. Furthermore, iBMG will have a part in the skills education programme for medical students. Finally, as mentioned elsewhere in this Activities Report as well, much has been achieved in the field of post academic education. Witness the foundation of the ‘Academy of Medical Specialists’, in which iBMG is partnering with the Dutch Order of Medical Specialists and the VVAA service organisation. Another good example is the accreditation of the master of Health Business Administration that is offered by the iBMG-affiliated Centre for Management Development in health care (CMDz). This all goes to show that education at and by iBMG is in perpetual motion: new modes of cooperation, better organisation of educational activities, great attention to recent developments in health care and in particular better education for our students. There is every reason, therefore, to look at the future in full confidence. 15
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
For the second time in a row it was selected the best health sciences bachelor's programme in the Netherlands
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
ó by Isabelle Fabbricotti, Assistant Professor The bachelor’s programme Health Policy and Management has been doing very well in the past year. For the second time in a row it was elected the best health sciences bachelor’s programme in the Netherlands. What’s more, enrolment has been highest ever since its start: in total 150 students registered for the bachelor. The number of graduates was 41. Also, the policy goal for international orientation was reached again. Some 15% of the students have taken part of the programme abroad. We should like to see this positive trend continue and have therefore set ambitious policy goals. The bachelor is to develop 16
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
gramme’s multidisciplinary character. In the coming year we intend to adjust the teaching methods, literature and assessment procedures to the new teaching objectives. To this aim the lecturers involved have drawn up development plans.
Education: Bachelor Health Policy and Management a
a
a
a
a
into a programme that guarantees academic level, intensification and multidisciplinary thinking. In the past year we worked on three projects central to this aim. The first was a large-scale 'academic orientation' project. This aimed at improving the agreement between final competences and course competences as well as raising the bachelor’s academic level. The RISBO institute was called in for help and we organised working conferences. Thus, we formulated criteria for the academic level, screened and synchronised the teaching objectives of all courses, and reformulated these in line with the final competences, the established criteria and the pro-
Second, the academic year 2007-2008 was dominated by preparations for the majorminor-structure. The third bachelor year was drastically revised to make room for the minors. Some courses were fully phased out and study load and contents of others were adapted. As a matter of course we implemented transitional measures and informed the students. iBMG itself has developed three minors: Public Health, in partnership with the Erasmus MC department of Public Health; Integrated Care Management; and Health and Healthcare in Developed and Developing Countries. Regrettably there were not enough registrations for the latter. We will be developing two other minors in the coming academic year, one of which will be taught in English. Reinforcing the skills line was a third project. Under this umbrella we set up a digital portfolio that will be further refined in the coming academic year, implemented a course on effective studying, performed a pilot on writing tests, and drew up an action plan aimed at improving skills education and at its roll-out in the second and third bachelor years. The coming year will be dedicated to further developing of these activities.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
ó by prof. Martin Buijsen The years 2007 and 2008 have again seen greater interest in the English-taught Master of Science in Health Economics Policy & Law. Enrolment in the past year was 55 students. In 2008 we have reached the point at which almost half of our ‘own’ iBMG-bachelors have opted for the HEPL-programme. This may be regarded a gratifying development as HEPL is considered to be very demanding, and not only because it is taught in English. To date approximately two thirds of the HEPL-population are iBMG-bachelors and one third students from abroad, lateral-entry students from the Netherlands and participants in the preparatory programme. In the near future we expect increasing student numbers, mainly because the iBMG-bachelor cohorts tend to grow and more students from these cohorts tend to choose HEPL. In the years 2007 and 2008 we have invested in the programme in various ways. A number of courses have been thoroughly revised with the use of educational innovation funds. Also, a new ‘elective’ was added to the curriculum: The Pharmaceutical Market. Launched in 2008, it met with great success. This new elective is part of a route which HEPL-students with a special interest in pharmaceutical care issues can follow since 2008. We intend to widen this route to become a true specialisation within the programme. In addition we will give the ‘Global Health’ theme a more prominent place. Plans for a new course on the subject are being elaborated. This course will be offered within the framework of a collaboration with the renowned Institute of Social Studies (ISS) in The Hague, which since recently is part of Erasmus University, and with the Erasmus MC department of Public Health. Substantive enrichment of the programme is also achieved by creating partnerships with institutions that provide education which is interesting and rele-
Considerable growth in number of students
Education: Master of Science in Health Economics, Policy & Law a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
vant to HEPL-students. For example, there is a long-standing good relation with the University of Oslo. And HEPL-students are able to take electives at the Bocconi University in Milan since 2007. A similar agreement with the sister faculty at Innsbruck is being prepared. The ultimate aim is to link these relations so as to form a solid European programme, which even could be supported financially by the Erasmus Mundus programme at a later stage. This network will offer future ‘hepleans’ the opportunity to follow a real international master’s programme. The HEPL-programme is confronted with two big challenges in the near future. For one, enrolment of foreign students has not increased over the years. Getting more
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
students from abroad will not come about by setting up a European network only. We also need enhanced visibility of the programme in other ways. In 2008, therefore, considerable efforts have been made to give the programme a presence on the Internet. Googling, everywhere in the world, will now quickly retrieve our programme. The second challenge concerns the programme’s ease of study. As mentioned above, the HEPL-programme is considered ‘very demanding’. Still, the challenge here is not so much the level of difficulty but rather the time needed to complete the programme. Relative few students manage to complete it within the one year that is nominally available. RISBO staff are helping us to find ways leading to a shorter average completion time. 17
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
ó by Kees van Wijk, Assistant Professor The Health Care Management master’s programme (Zoma) educates students to be academically-trained managers who are capable of playing a leading role in complex health care situations. A balanced curriculum provides for courses that cover all administrative and management aspects relating to health care organisations. The programme is sustained by qualified and enthusiastic lecturers who all know the complex health care sector like the back of their hand. Theoretical principles are translated into practice through case studies, so that students learn to apply the taught knowledge. 18
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
The information provision about the international exchange programmes with our foreign partners in Milan (Boconi University) and Oslo (Oslo University) has received great attention. Furthermore, students have been extensively informed about the importance of the master’s dual stream trainee period. In this stream they can gain (other) management experience under the supervision of the dual stream coordinator and the manager they are ‘assisting’. In many cases students also prepare their graduation project in the traineeship organisation.
Education: Master of Science in Health Care Management a
a
help students integrate the course contents more effectively. This is in the shape of an Integration case, which entails that in each trimester a real life case is the work material for assignments. This is intended to become a form of projectoriented learning. Assignments on problems of real organisations should stimulate students to integrate the subject matter. In the academic year 2008-2009 students are invited to give direct feedback so that we can make adjustments. We expect to arrive at the definitive form in the academic year 2009-2010.
The programme has proven to be successful
a
a
a
a
a
a
a
a
The enrolment statistics prove that this formula is successful. Seventy-three students started with the Zoma programme in 2007. For 24 of these this followed on to the iBMG bachelor Health Policy and Management, 41 entered via the preparatory programme, and eight students of other universities were directly admitted to the master. Of this class, 39 students graduated within one year. In addition, nine students in the part-time variant earned their degree in 2008. The year 2008 saw a considerably higher enrolment, i.e. 113 student, of whom 21 from the bachelor, 75 from the preparatory programme and 17 via other bachelor's or master's programmes. In the report period we started a project to
The programme’s academic orientation requires continuous attention. Apart from the applied assignments, tutorials will be held in which there is a stronger focus on the scrupulous review of scientific articles. With regard to international orientation, on the one hand the recruitment of students for exchange programmes will be intensified (see the above point) and, on the other hand, some courses of the curriculum will be offered in English. The curriculum is successful, but has already been functioning for several years. It is time for quality maintenance: to hold to the light the teaching objectives, subjects, competence-orientedness, the assignments, assessment procedures, cases and educational methods. The servicing has started in 2008.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
solid market position. On the one hand, the programmes keep attracting new managers, directors and professionals; on the other hand, we may pride ourselves on a bunch of faithful friends who enrol in different programmes.
Academy for Medical Specialists ó by Pieter Wijsma, Director of Academy MS
Post Academic Education: Erasmus CMDz ó by prof. Pauline Meurs, Director of Erasmus CMDz The year 2008 was a rewarding year for the Erasmus Centre for Management Development in health care (CMDz). We have made preparations for the accreditation of our executive MBA Health and were pleased to learn that early 2009 this programme was granted European accreditation for a period of five years. Applicants were quick to respond and just like in previous years in 2008 a new group of health care managers started with the programme. All participants of class 20072008 have been awarded their degree. The Top Class, a one-year programme for prospective managing directors, again needed to place applicants on a waiting-
list. With its growing reputation the Top Class draws overwhelming interest. As group composition is one of the key factors for success, participants are scrupulously selected. Yearly we admit 22 or 23 health care managers and professionals from the different sectors. The Master Class – which gave Erasmus CMDz its good reputation – is our longest running programme. Fully refreshed quite recently, it yearly admits 20 experienced directors. We provide a state-of-the-art overview of developments in policy and management and there is ample room for exchange of experience. Furthermore, for ‘connoisseurs’ we have specific programmes on the menu. For example, financial management for nonfinancially trained persons. This short course was taught twice in 2008 as well. Another example is ‘values of health care’. As indicated by its name, this programme is concerned with the underlying values of management. In 2008 we have composed an invited group of seventeen directors with final responsibility in their organisations. Erasmus CMDz has been able to secure a
At the closing of the year 2008 iBMG, together with the Dutch Order of Medical Specialists and VVAA – a service organisation for (para)medics – established the Academy for Medical Specialists. The Academy provides post graduate training for medical specialists and representatives of other disciplines (such as pharmacists and clinical psychologists) in hospitals and mental health organizations. The courses encompass a wide range of topics, related to the six so-called CanMeds-roles: Communicator, Collaborator, Manager, Health Advocate, Scholar and Professional (so all roles except that of Medical Expert). For example: medical management, hospital finances, negotiation, collaboration, appraisal and assessment, quality audits, time management, patient communication, etc. Apart from the courses with open access for individual medical specialists, the Academy provides in-company courses, individual and group coaching, international study trips and conferences, as well as courses on hospital management for fellows. The Academy is a successor to the Foundation for Management Education for Medical Specialists, in which iBMG partnered with the Order of Medical Specialists since 1990. Educational quality is monitored by a Programme Council of senior medical specialists and hospital CEOs. 19
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
I fell for it at once
Interview with former student Igna Bonfrer
Always in search of a challenge a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
So what made you decide to go and study at our institute? When I was in secondary school my careers councillor drew my attention to Health Policy and Management; a programme that catered for my combined interests in the medical world and the organisation of activities. I fell for it at once. Although I was advised against it, in September 2004 I started with both the health sciences bachelor’s programme and econometrics and left Erasmus University four years later with two MSc degrees: Health Economics, Policy & Law (cum laude) and Econometrics & Management Science. What was your first impression of iBMG? Right from the start I felt at home at iBMG. The first course, Introduction to Health Care, was bang on the target. We learned 20
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Could you tell more about your extracurricular activities? In my second year I became Commissioner Education & External Relations of the faculty association FBMG. That was the year I introduced the Lecturer of the Year election, to name but one thing. The following year I was active as chairperson of the student body representation in the University Council, a nice way to see what is happening on a higher level in the university. As a student-assistant to iBMG, I held working group sessions for bachelor students and did work for third parties, such as RIVM, the National Institute for Public Health and the Environment. From all this I could learn how to effectively work together with others at different levels.
photo: dazed photography
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
about the general structure of health care in the Netherlands and about the core disciplines within iBMG. It took some time to get used to the method of Problem Oriented Education, but then I got in a short time a much better picture of the challenges inherent to our health care system. How do you feel about the iBMG education? The bachelor was interesting but not always that challenging. So next to it I and my fellow students started to set up all kinds of (programme-related) activities, including a study trip to Uganda. The MSc in Health Economics, Policy & Law was more challenging and therefore more appealing. I had to really commit myself and go into the deep end. In combination with my Econometrics master this made me experience a tough, but satisfactory year.
What are you doing now? I went to the University of Oxford in England and am doing an MSc in History of Science, Medicine and Technology. A great experience; getting tutored in the professor’s room with just one other student. All of Oxford is dedicated to scientific research and you learn quite a lot. I am also active as President of the Graduate Common Room, a student board for a group of 500 students. What are your plans for the future? If all goes well I will start with my PhD study at iBMG in January 2010. My subject is the introduction of health insurance in developing countries and my supervisor is Prof. dr. Eddy van Doorslaer. Although there are opportunities in Oxford, I’d like to take advantage of the available knowledge on health economics in iBMG. Perhaps l’d like to switch over to a managerial position in health care later; for this was my initial interest, wasn’t it? Whatever, my iBMG training has provided me with a very solid basis which I can turn to good use for life.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
21
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Management affairs a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
ó by Marieke Veenstra, Manager
22
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
the educational and research programmes and the organisation. In this regard, we are paying much attention to educational quality and service provision to students and lecturers. The education marketing is being professionalized, and marketing is targeted at international students as well. Joint activities are carried out in partnership with the alumni association in order to keep alumni involved with iBMG. The research domain is benefiting from the appointment of a policy officer who assists the research director and finds ways to further professionalize the research organisation. Close contact is being maintained with the PhDstudents united in ‘young BMG’. They will bring up common interests that may help to enhance the research climate. Furthermore, great efforts are being made to improve the education and supervision of PhD-students.
The institute is booming and blooming
a
a
a
a
a
a
The years 2007 and 2008 were characterized by highly dynamic developments.
to socialize and to get to know one another. So the institute is steadily developing into a mature and professional organisation.
To begin with, iBMG reached its 25th birthday in 2007. This milestone was celebrated with great enthusiasm by all staff. They took part in social activities held around the 25th each month. The Van Nelle Fabriek in Rotterdam was the venue for the grand closing festivities in November. The birthday celebrations went a long way to fulfilling the wish of all staff to get more involved with the institute and with each other. Following on to this, seminars and workshops for researchers were held at set times. Internal communication was improved by setting up an intranet site and publishing a BMG journal. Social activities and events offer the opportunity
Healthy growth Getting to know one another is important because iBMG is growing healthily. We are much investing in recruitment of new top talents. Thus, in 2007 and 2008 we welcomed no fewer than eight professorial appointments. For that matter, the number of other staff grew considerably as well, in 2007 by 5% and in 2008 by 28% to 117.4 fte (excluding iMTA and Erasmus CMDz). These growth figures are in line with the earlier described developments in education and research and will continue to increase in the coming years. In the past years iBMG has created a solid financial buffer that allows investing in
New setting The institute’s growth necessitated a move to a new location on campus Woudestein. The four floors in J-building that have been made available to iBMG provide sufficient room for growth. An interior designer created an ambience that does justice to iBMG’s ambitions. All staff have had a say in the matter so that the design reflects the institute’s identity and provides a stimulating work environment. There is ample space where people can meet and share knowledge. All services have been accommodated on one floor; visitors are received here and we find a communal luncheon table, a coffee bar, an attractive meeting room and seating areas. The other floors, too, provide shared facilities apart from the office spaces, in a stimulating and cosy ambience. All this means a great improvement for staff and visitors alike. Transfer to EUR By the close of 2008 it was decided that iBMG would return to Erasmus University Rotterdam. The institute will remain linked
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Board of Directors Erasmus MC
Chairman iBMG
Holding
Education Director
Manager
Administrative Office
iMTA
Erasmus CMDz
Examination Board
Academy MS
Education Board
Section
Section
Section
Section
Section
Health Economics/ iMTA
Health Care Governance
Health Care Management
Health Law
Health Insurance
to Erasmus MC, but all staff will be employed by EUR as from 1 January 2010. After transfer, iBMG’s house style will conform to that of EUR. It follows that the next activities report will have a brand new look. Irrespective of this shift iBMG is
eager to reinforce project cooperation with Erasmus MC and the EUR faculties and institutes. So far, substantial collaborations in the fields of health economics, health logistics and health law have been formed. Proposed health domain collabo-
rations concern patient safety, global health, social sciences and business administration. The common goal is to create a strong knowledge centre in Rotterdam in the field of health policy and management. 23
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Facts & Figures
Education Number of students Bachelor 1 Bachelor 2 Bachelor 3 Pre-master Master Zoma Master HEPL
Post Academic (Erasmus CMDz)
2006-2007
2007-2008
106 68 70 71 96 61
146 80 70 125 72 52
472
545
296
230
2007
2008
9
7
2007
2008
91.7 15.0 8.1
117.4 14.0 7.2
114.8
138.6
Research
Number of PhD theses
Staff Fte iBMG iMTA CMDz
24
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Academic staff 2007-2008
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Section Health Care Governance J.E.C.M. Aarts, S.A. Adams, R.A. Bal, M.P.M.
Section Health Care Management B. Bakker-van der Meij, C.T. Boon, T. Broer, M.
Bekker, A.A. de Bont, H.M. van de Bovenkamp, E. den Breejen, J. Dwarswaard-
Buljac, B.F. Buys-Ballot, J.M. Cramm, C.M. Dekker-van Doorn, A.J.A. Donkers, I.N.
de Snoo, C. van Egmond, J. van Ellinkhuizen, T.E.D. van der Grinten, K.J. Grit,
Fabbricotti, H.J.M. Finkenflügel, J. Geelhoed, I.M. van de Glind, M.A. Goossensen,
E. Huisman, Y.J.F.M. Jansen, S. Jerak-Zuiderent, W.G.M van der Kraan, E. van Loon,
A.S. Groenewoud, J. Holland, R. Huijsman, B.M. van Ineveld, D.F. de Korne,
P.L. Meurs, M.G.H. Niezen-van der Zwet, H. Pirnejad, K. Putters, A.L. van Staa,
L. Kreuger, K.M.M. Lemmens, H. Machielsen, P. Makai, A.P.W.P. van Montfort,
A.M.V. Stoopendaal, M.J. Trappenburg, J.A. Verhulst, I. Wallenburg, R.L.E.
M. de Mul, A.P. Nieboer, K.J. Nijmeijer, V.C. Pijpers, G.R.M. Scholten, S.S. Slaghuis,
Wehrens, T. Zuiderent-Jerak
M. Stoffer, M.M.H. Strating, E. Suurland, R.B. Teng, M.F.A. Veld, J.M.H. Vissers, G. de Vries, J.W.M. Weggelaar-Jansen, E.J. van de Wetering, K.P. van Wijk, J.D.H.
Section Health Law M.A.J.M. Buijsen, A.P. den Exter, H.E.G.M. Hermans,
van Wijngaarden, M.M. ten Wolde, J.J. Zuurbier
E.H. Hulst, B. Megens, T.J.C. van Noord, F. Paolucci, M. San Giorgi, S.P. Zinzombe Erasmus CMDz S.H. Boomsma, E.J. Breedveld, H.P.J. Buiting, M. Derks, Section Health Insurance L.H.H.M. Boonen, D. de Bruijn, R.C. van Kleef, T. Laske-
K.H. Harms, J. Meems, T.M.D. Ngo, E.M. Ott, A.A. de Roo, W.K. van der Scheer
Aldershof, F.T. Schut, M. Varkevisser, W.P.M.M. van de Ven, R.C.J.A. van Vliet Guest lecturers and researchers / External PhD students J.C. Bouvy, F. Dekker, Section Health Economics / iMTA M.J. Al, A.E. Attema, S.A. Baeten, H. Binnendijk,
J. van der Eijk, L.C. Faverey, M. Gauthan, J. de Goede, J.S. de Koning, M.M.N.
E. Birnie, H. Bleichrodt, A. Bobinac, G.J. Bonsel, C.A.M. Bouwmans-Frijters, W.B.F.
Minkman, F.E. van Nooten, M.J.C. Nuijten, H.C. Ossebaard, Z. Pirnejad-Niazkhani,
Brouwer, A.A. Chote-Omapersad, J.P. Cohen, S. Denktas, E.K.A. van Doorslaer,
L.R. Pol, B.J. Roosenschoon, H.H.M. Scholtes, N.A.F.M. Schreiner, P.J.A. Stam, J.U.
D.M. Dror, N.J.A. van Exel, M. Filko, M.M.E. Foets, M.G. Franken, J.G. Gaultney,
Stoelwinder, C.J. Tilling, J.M. Tromp, E.J. van Vliet, S.P.M. de Waal, J.P. Weemers,
C.W.M. van Gils, L.M.A. Goossens, J.A. Haagsma, L. Hakkaart-van Roijen,
J.W. Wijnia, S. Winters, W. Xu, G.H. Zwart
R.J. Hoefman, L. Holdermans, K.M. Holtzer-Goor, E.J.I. Hoogendoorn-Lips, A.C. ten Hove, T. Jansen, T.A. Kanters, A. van Klooster-Rutteman, C. Koedoot, A.H.E. Koolman, G.T. Koopmans, M.A. Koopmanschap, H.M. Krol, A. Leunis, C.A.M. de Meijer, L.W. Niessen, M. Oppe, L.S.W.M. Peerboom, M.J. Poleij, J.M. Pomp, D.R. Rappange, W.K. Redekop, F.F.H. Rutten, M.P.M.H. Rutten-van Mölken, S.J. Schawo, H.M. Sonneveld, A. Spreij, A. Steenhoek, E.A. Stolk, S.S. Tan, C.A. Uylde Groot, P. Vemer, A. de Vries
25
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
PhD graduates & Inaugural lecture
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Nihes evaluation iBMG’s research is embedded in the Nihes (Netherlands Institute for Health Sciences) research school. An independent international committee evaluates all Nihes research programmes every five years. The most recent evaluation (2002-2006) rates iBMG’s research as ‘very good’ to ‘excellent’. See abstract below. Abstract
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
The research at this department is of very good to excellent quality (score 4.5). The department harbours several scientists who are world leading in their field of research, and the societal
PhD graduates 2007
impact of the work is very high. The research within the department is concentrating on the health care reform in the Netherlands, being the first country to implant a regulated competition
Bekker, M.P.M. The politics of healthy policies redesigning health impact assessment to integrate health in public policy.
model. This is a very interesting line of research with great opportunity for other countries to learn from this natural experiment. This means that thorough evaluation is needed, and the Committee strongly advises to include evaluation of the effect of the reform on patient needs and outcomes.
Fabbricotti, I.N. Zorgen voor Zorgketens: Integratie en fragmentatie in de ontwikkeling van zorgketens.
Score definitions 5. Excellent Work that is at the forefront internationally, and which most likely will have an
Helderman, J.K. Bringing the market back in institutional complimentarity and hierarchy in Dutch housing and health care?
important and substantial impact in the field. Institute is considered an international leader. 4. Very good Work that is internationally competitive and is expected to make a significant contribution; nationally speaking at the forefront in the field. Institute is considered international
Hoek, H. Governance & gezondheidszorg: Private, publieke en professionele invloeden op zorgaanbieders in Nederland.
player, national leader. 3. Good Work that is competitive at the national level and will probably make a valuable contribution in the international field. Institute is considered internationally visible and a
Paolucci, F. The design of basic and supplementary health care financing
national player.
schemes: implications for efficiency and affordability. 2. Satisfactory Work that is solid but not exciting, will add to our understanding and is in Stam, P.J.A. Testing the effectiveness of risk equalization models in health insurance: a new method and its application.
principle worthy of support. It is considered of less priority than work in the above categories. Institute is nationally visible. 1. Unsatisfactory Work that is neither solid nor exciting, flawed in the scientific and or technical
Uiters, A.H. Primary health care use among ethnic minorities in the
approach, repetitions of other work, etc. Work not worthy of pursuing.
Netherlands: a comparative study.
Wijk, K.P. van The Service Care Chain. The influence of service and HRM on the
Oostrik, F.G.H. Als je het mij vraagt.
realization of demand-driven care by care organisations.
Waarom mensen kiezen voor zelfbeschikking (PGB) in de zorg.
Zuiderent-Jerak, T. Standardizing healthcare practices; experimental
Pirnejad, H. Communication in Healthcare opportunities for information
interventions in medicine and science and technology studies.
technology and concerns for patient safety.
Stoopendaal, A.M.V. Zorg met afstand. Betrokken bestuur in grootschalige
PhD graduates 2008
zorginstellingen.
Boon, C.T. HRM and Fit. Survival of the Fittest!
Witman, Y. De medicus maatgevend; over leiderschap en habitus.
El Fakiri, F. Prevention of cardiovascular diseases in deprived neighbourhoods.
Inaugural lecture 2008 Groenewoud, A.S. It's your choice! A study of search and selection processes, and the use of performance indicators in different patient groups.
Bal, R. De nieuwe zichtbaarheid. Sturing in tijden van marktwerking, Rotterdam: Erasmus MC.
26
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Academic publications 2007
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Prinsze, F.J. & Vliet, R.C.J.A. van (2007). Health-Based Risk Adjustment: Improving the Pharmacy-Based Cost Group Model by Adding Diagnostic Cost Groups. Inquiry. A Journal of Medical Care Organization, Provision and Financing, 44, 469-480.
Varkevisser, M. & Geest, S.A. van der (2007). Why do patients bypass the nearest hospital? An empirical analysis for orthopaedic care and neurosurgery in the Netherlands. European Journal of Health Economics (HEPAC), 8, 287-295. a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Ven, W.P.M.M. van de, Beck, K., Voorde, C. van de, Wasem, J. & Zmora, I. (2007).
Research line: Competition and regulation in health care
Risk adjustment and risk selection in Europe: 6 years later. Health Policy, 83, 162-179.
Article/Letter to the editor Book (chapter) Agyemang, C., Bhopal, R. & Redekop, W.K. (2007). Does the pulse pressure in people of European, African and South Asian descent differ? A systematic review
Buijsen, M.A.J.M. (2007). Wet- en regelgeving in de zorg. Inleiding
and meta-analysis of UK data. Journal of Human Hypertension, 21, 598-609.
gezondheidsrecht. Eindhoven: SBO.
Danis, M., Binnendijk, E., Ost, A., Vellakkal, S., Koren, R. & Dror, D.M. (2007).
Buijsen, M.A.J.M. (2007). Wet- en regelgeving in de zorg. Rechtshandhaving in
Eliciting the Health Insurance Benefit Choices of Low-income Populations in
de gezondheidszorg. Eindhoven: SBO.
India with the CHAT Exercise. Social Science & Medicine, 64(4), 884-896. Buijsen, M.A.J.M. (2007). Wet- en regelgeving in de zorg. Eindhoven: SBO. Dror, D.M., Koren, R., Ost, A., Binnendijk, E., Vellakal, S. & Danis, M. (2007). Health Insurance benefit packages prioritized by low-income clients in India: Three criteria
Buijsen, M.A.J.M. (2007). De autonomie van de dokter. In F.H.J.G. Brekelmans,
to estimate effectiveness of choice. Social Science & Medicine, 64, 884-896.
M.A.J.M. Buijsen, M. van Es, P.W.A. Huisman & B.P. Vermeulen (Eds.), De docent: onderdaan of autoriteit? (pp. 85). Den Haag: Sdu Uitgevers.
Dror, D.M. (2007). Micro Health Insurance in India: Pointers for Progress. IRDA Journal, 5(12), 7-11.
Buijsen, M.A.J.M. (2007). De betekenis van solidariteit in de gezondheidszorg. In M.A.J.M. Buijsen, W. van de Donk & N. van Gestel (Eds.), Marktwerking versus
Dror, D.M. (2007). Why ''one-size-fits-all'' health insurance products are
solidariteit (3, 3) (pp. 65-5). Venlo: Thijmgenootschap.
unsuitable for low-income persons in informal economy in India. Asian Economic Review, 49(1), 47-56.
Buijsen, M.A.J.M. & Exter, A. den (2007). Gelijkheid en het recht op gezondheidszorg. In A. den Exter (Ed.), Sociaal-Economisch recht Gelijkheid en
Dror, D.M., Rademacher, R. & Koren, R. (2007). Willingness to pay for health
recht op zorg (pp. 13-1). Nijmegen: Ars Aequi Libri.
insurance among rural and poor persons: Field evidence from seven micro health insurance units in India. Health Policy, 82(1), 12-27.
Grinten, T.E.D. van der & Drewes, J. (2007). Zorgverzekeraar & preventie nieuwe kansen of business as usual? In Jaarboek Publieke Gezondheid 2007 (pp. 154-3).
Enthoven, A.C. & Ven, W.P.M.M. van de (2007). Going Dutch - Managed-
Abcoude: Forum Stichting Public Health Forum.
Competition Health Insurance in the Netherlands. New England Journal of Medicine, 357(24), 2421-2426.
Foets, M.M.E., Schuster, J. & Stronks, K. (2007). Gezondheids(zorg) onderzoek onder allochtone bevolkingsgroepen. In M. Foets, J. Schuster & K. Stronks (Eds.),
Kleef, R.C. van, Beck, K., Ven, W.P.M.M. van & Vliet, R.C.J.A. van (2007).
Gezondheids(zorg) onderzoek onder allochtone bevolkingsgroepen.
Does risk equalization reduce the viability of voluntary deductibles?
Amsterdam: Askant.
International Journal of Health Care Finance and Economics, 7, 43-58. Helderman, J.K. & Grinten, T.E.D. van der (2007). Bevorderen, voorkomen Paolucci, F., Schut, F.T., Beck, K., Gress, S., Voorde, C. van de & Zmora, I. (2007).
genezen en ondersteunen. In Volksgezondheid en gezondheidszorg in de
Supplementary health insurance as a tool for risk-selection in mandatory basic
verzorgingsstaat (pp. 195-8). Den Haag: Lemma.
health insurance markets. Health Economics, Policy and Law, 2, 173-192.
27
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Hermans, H.E.G.M. (2007). Het recht op noodzakelijke zorg. In Gelijkheid en
Putters, K., Meurs, P.L. & Schulz, M. (2007). Van government naar governance in
recht op zorg (pp.-2). Nijmegen: Ars Aequi Juridische Uitgeverij.
de hybride sectoren zorg en onderwijs. In G. Minderman (Ed.), Governance in hybride sectoren. Den Haag: Sdu Uitgevers.
Hermans, H.E.G.M. (2007). Mededingingsrechtelijke aspecten en rol, werking en inrichting van de Zorgautoriteit. In J.J. Zuurbier & Y. Krabbe-Alkemade (Eds.),
Putters, K. & Frissen, P.H.A. (2007). Vertrouwen voor en door innovatie Over de
Onderhandelen over DBC's (pp. 143-8). Maarssen: Elsevier Gezondheidszorg.
noodzaak van checks & balances bij vernieuwingsprocessen in de zorg. Tilburg: Universiteit Tilburg.
Hermans, H.E.G.M. & Donk, R.N. van (2007). Overeenkomstenstelsel zorg Gezondheidswetgeving in de praktijk. In Overeenkomstenstelsel zorg. Houten:
Schut, F.T. (2007). Concurreren in de GGZ: economisch verantwoord?
Bohn Stafleu van Loghum.
In J.N. Keeman, P.W. Leeuw, J.A. Mazel & F.G. Zitman (Eds.), Het medisch jaar 2007. Houten: Bohn Stafleu van Loghum
Hermans, H.E.G.M. (2007). Tekst en toelichting Zorgverzekeringswet. In Tekst en toelichting Zorgverzekeringswet. Den Haag: Sdu Uitgevers.
Vrielink, M., Hout, E.J.Th. van & Putters, K. (2007). Governance van lokale zorgen dienstverlening. In E.M.H. Cornelissen, P.H.A Frissen, S. Kensen & T. Brandsen
Hermans, H.E.G.M. (2007). Ziekenhuizen in een gelaagde en pluriforme
(Eds.), Betoverend Bestuur; Legitimiteit, vitaliteit, meervoudigheid (pp. 241-12).
rechtsorde. In A.C. Hendriks & H.M. ten Napel (Eds.), Volksgezondheid in een
Den Haag: Lemma.
veellagige rechtsorde Eenheid en verscheidenheid van norm en praktijk (pp. 153-11). Alphen aan den Rijn: Kluwer.
Article in Dutch journal Hout, E. van & Putters, K. (2007). Leiderschap in maatschappelijke organisaties. In E.M.H. Cornelissen, P.H.A. Frissen, S. Kensen & T. Brandsen (Eds.), Betoverend
Akveld, J.E.M. & Hermans, H.E.G.M. (2007). Commentaar op rapport over
Bestuur; Legitimiteit, vitaliteit, meervoudigheid (pp. 219-11). Den Haag: Lemma.
toekomst Rijksvaccinatieprogramma. Zorg & Financiering, 4, 16-19.
Hulst, E.H. (2007). Wet- en regelgeving in de zorg 6. Patiëntenrechten in de
Akveld, J.E.M. & Hermans, H.E.G.M. (2007). Duits onderzoek bevestigt:
gezondheidszorg. Eindhoven: SBO.
systeemverandering orgaandonatie is nu noodzakelijk. Zorg & Financiering, 10, 23-25.
Hulst, E.H. (2007). Wet- en regelgeving in de zorg 7. Patiëntenrechten in de gezondheidszorg. Eindhoven: SBO.
Akveld, J.E.M. & Hermans, H.E.G.M. (2007). Nivel-rapport toont falen van huidige wet op de orgaandonatie aan. Zorg & Financiering, 8, 23-26.
Noord, T.J.C. van & Hulst, E.H. (2007). Wet- en regelgeving in de zorg 13. Preventiewetgeving en wetgeving openbare gezondheidszorg. Eindhoven: SBO.
Berg, B. van den, Stam, P.J.A. & Laske-Aldershof, T. (2007). Preferenties voor kwaliteit van zorg gemeten met de vignettenmethode. TSG, 85(6), 345-353.
Putters, K., Hout, E.J.Th. van & Cardoso Ribeiro, T. (2007). Consequenties van de Wet Maatschappelijke Ondersteuning. In De zorg van het lokaal bestuur. Assen:
Berg, B. van den, Stam, P.J.A. & Laske-Aldershof, T. (2007). Het meten van
Van Gorcum.
kwaliteitsvoorkeuren in de zorg. Tijdschrift voor Politieke Ekonomie, 28(1), 82-92.
Putters, K., Helderman, J.K. & Grinten, T.E.D. van der (2007). Gezondheidszorgonderzoek: de bestuurswetenschappelijke invalshoek. In T. Plogch, R.E.
Boonen, L.H.H.M. & Schut, F.T. (2007). Effect van prikkels op keuze voor
Juttman, N.S. Klazinga & J.P. Mackenbach (Eds.), Handboek Gezondheidszorg
zorgaanbieders. Economisch Statistische Berichten, 2, 651-653.
(pp. -15). Houten: Bohn Stafleu van Loghum. Bosschaart, A.N., Hulst, E.H. & Haan, F. de (2007). De plicht van iedere Putters, K. (2007). Marktgedrag en innovatie: over de ruimte voor innovatie
hulpverlener. Medisch Contact, 62(48), 1984-1987.
tussen samenwerking en concurrentie. In Marktgedrag en innovatie Over de ruimte voor innovatie tussen samenwerking en concurrentie. Leiden: STG
Buijsen, M.A.J.M. (2007). Centrale vraagstukken in de bioethiek. TGE. Tijdschrift
Health Management Forum.
voor Gezondheidszorg & Ethiek, 17(4), 127-128.
Putters, K. (2007). Passende instrumenten voor onderwijsbeleid. In Beleids-
Buijsen, M.A.J.M. (2007). Werken aan de werkelijkheid Imagocampagne:
instrumenten in het onderwijs. Den Haag: Onderwijsraad.
nee Imagocampagnes voor de zorg zijn weggegooid geld. Het gaat om tevredenheid van verpleegkundigen. Nursing, 13, 18-18.
28
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Geest, S.A. van der, Mosca, I., Pellikaan, F. & Varkevisser, M. (2007). In beweging
Kleef, R.C. van, Ven, W.P.M.M. van de & Vliet, R. van (2007). Een effectiever eigen
voor de fysiotherapeut. Economisch Statistische Berichten, 4516, 506-508.
risico in de zorg. Economisch Statistische Berichten, 92(4515), 459-461.
Grinten, T.E.D. van der (2007). Ondernemen voor de zorg. M&O, 61(2), 209-214.
Luijkx, K.G. & Putters, K. (2007). Prosumerisme in de zorg. TSG, 8(6), 307-311.
Grinten, T.E.D. van der (2007). Stelselherziening van de Nederlandse
Meindertsma, M. & Putters, K. (2007). De herontdekking van nationale
gezondheidszorg. TSG, 85(4), 227-233.
kaderstelling. Proeflokaal, 22, 13-21.
Hermans, H.E.G.M. (2007). Belangrijk nieuws arrest Europese Hof over
Putters, K. (2007). Twee handen op een buik? Levert het spanningsveld tussen
vergoeding ziekenhuiskosten buitenland. Zorg & Financiering, 5, 106-108.
concurreren en samenwerken innovatiekracht op? HMF, 2, 7-11.
Hermans, H.E.G.M. (2007). Conclusie Advocaat-Generaal bij de Hoge Raad over
Putters, K. & Twist, M.J.W. van (2007). Bijdragen aan beleid of tegenspel
Europees aanbesteden door Amphia gunstig voor ziekenhuizen. Zorg &
bieden? Modaliteiten voor een vernieuwd adviesstelsel.
Financiering, 4, 28-29.
Bestuurswetenschappen, 61(2), 11-19.
Hermans, H.E.G.M. (2007). NZA publiceert beleidsregel aanmerkelijke
Putters, K. (2007). Een PvdA keurmerk voor de WMO. Proeflokaal, 7(24), 19-26.
a
a
a
a
a
a
a
a
marktmacht in de zorg. Zorg & Financiering, 8, 29-31. Schut, F.T. (2007). Collectieve zorgverzekeringen: opkomst, kenmerken en Hermans, H.E.G.M. (2007). Aanbestedingsplicht ziekenhuizen door recente
betekenis. Zorg & Financiering, 6, 10-21.
rechtspraak definitief van de baan? Zorg & Financiering, 9, 9-17. Schut, F.T. (2007). Pas op de plaats nodig voor nieuwe stap voorwaarts. Christen Hermans, H.E.G.M. (2007). Uitspraak college van beroep voor het bedrijfsleven
Democratische Verkenningen, 28(3), 128-137.
over vergoeding kosten MRSA in de zaak valkenhof tegen NZa. Zorg & Financiering, 1, 51-53.
Schut, F.T. (2007). Wordt de zorg een markt? M&O, 61(2), 191-202.
Hermans, H.E.G.M. (2007). Wat mij opvalt… Facelift of 'Extreme Makeover' voor oude dame? Zorg & Financiering, 5, 1-1.
Research line: Quality and efficiency in health care
Hermans, H.E.G.M. (2007). Wat mij opvalt... Verdere afslanking aantal
Article/Letter to the editor
toezichthouders is mogelijk. Zorg & Financiering, 8, 967. Abdellaoui, M., Bleichrodt H. (2007). Eliciting Gul's Theory of Disappointment Hermans, H.E.G.M. (2007). Wat mij opvalt... Zorg voor onverzekerden:
Aversion by the Tradeoff Method. Journal of Economic Psychology 28, 631-645.
begripsverwarring en onnodige beperkingen. Zorg & Financiering, 2, 168-168. Abdellaoui, M., Bleichrodt, H. & Paraschiv C. (2007). Loss Aversion under Prospect Hermans, H.E.G.M. (2007). Zijn zorginstellingen sinds het Amphia-arrest nog
Theory: A Parameter-Free Measurement. Management Science 53, 1659-1674.
aanbestedingsplichtig? Nederlands Juristenblad (NJB), 31, 1637-1637. Adams, S.A. & Bont, A.A. de (2007). Information Rx: Prescribing Good Hulst, E.H. (2007). Is een arts te allen tijde verplicht tot reanimatie over te gaan,
Consumerism and Responsible Citizenship. Health Care Analysis, 15(4), 273-290.
ook als de arts en college unaniem van mening zijn dat dit een zinloze medische handeling is? Internisten Vademecum, 13(6).
Adams, S.A. & Bont, A.A. de (2007). More than just a mouse click: Research into work practices behind the assignment of medical trust marks on the World
Hulst, E.H. (2007). Is een arts te allen tijde verplicht tot reanimatie over te gaan,
Wide Web. International Journal of Medical Informatics, 76S, S14-S20.
ook als de arts en collegae unaniem van mening zijn dat dit een zinloze medische handeling is? Reumatologen Vademecum, 10(20).
Adams, S.A. (2007). Using bloggings tools to help individuals record their experiences: an exploration web applications in the Netherlands. Information
Hulst, E.H. (2007). Wanneer eindigt de verantwoordelijkheid van de huisarts en
Technology in Health Care, 130, 193-203.
wanneer begint die van het ambulancepersoneel? Vademecum, 1-1. Baal, P.H.M., Brouwer, W.B.F., Hoogeveen, R.T. & Feenstra, T.L. (2007). Increasing tobacco taxes: A cheap tool to increase public health. Health Policy, 82, 142-152.
29
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Baal, P.H.M., Feenstra, T.L., Hoogenveen, R.T., Wit, G.A. de & Brouwer, W.B.F.
Cohen, J., Faden, L., Predaris, S. & Young, B. (2007). Patient access to pharma-
(2007). Unrelated medical care in life years gained and the cost utility of primary
ceuticals: an international comparison. European Journal of Health Economics
prevention: in search of a 'perfect' cost-utility ratio. Health Economics, 16, 421-433.
(HEPAC), 8, 253-266.
Bal, R. & Mastboom, F. (2007). Engaging with Technologies in Practice:
Cohen, J. (2007). The new Dutch health insurance system and its implications
Travelling the Northwest Passage. Science as Culture, 16(3), 253-266.
for pharmaceutical innovation. International Journal of Pharmaceutical and
a
Healthcare Marketing, 1(3), 214-225. Bal, R., Mastboom, F., Spiers, H.P. & Rutten, H. (2007). The product and process of referral optimizing general practitioner-medical specialist interaction
Cohen, J.P., Faden, L., Predaris, S. & Young, B. (2007). Patient access to pharma-
through information technology. International Journal of Medical Informatics,
ceuticals: an international comparison. European Journal of Health Economics
76, 28-34.
(HEPAC), 8, 253-2696.
Baltussen, R.M.P.M., Asbroek, A.H.A. ten, Koolman, A.H.E., Shrestha, N.,
Cohen, J.P., Stolk, E.A. & Niezen, M.G.H. (2007). The Increasingly Complex
Bhattarai, P. & Niessen, L.W. (2007). A Rational multi criteria approach to
Fourth Hurdle for Pharmaceuticals. Pharmacoeconomics, 25(9), 727-734.
Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? Health Policy and Planning, 22, 178-185.
Cohen, J.P. (2007). The new Dutch health insurance system and its implications for pharmaceutical innovation. International Journal of Pharmaceutical and
Bleichrodt, H. (2007). Reference-dependent utility with shifting reference points
Healthcare Marketing, 1(3), 214-225.
and incomplete preferences. Journal of Mathematical Psychology, 51, 266-276. Cuijpers, P., Smit, F., Oostenbrink, J.B., Graaf, R. de, Have, M. ten & Beekman, A. Bleichrodt, H., Abellan-Perpiñan, J.M., Pinto, J.L. & Mendez-Martinez, I. (2007).
(2007). Economic costs of minor depression: a population-based study. Acta
Resolving Inconsistencies in Utility Measurement under Risk: Tests of
Psychiatrica Scandinavica, 115, 229-236.
Generalizations of Expected Utility. Management Science 53, 469-482. Doorslaer, E.K.A. van, O’Donnell, O., Rannan-Eliya, R.P., Somanathan, A., Bont, A.A. de, Stoevelaar, H. & Bal, R. (2007). Databases as policy instruments.
Adhikari, S.R., Akkazieva, B., Harbianto, D., Garg, C.C., Hanvoravongchai, P.,
About extending networks as evidence-based policy. BMC Health Services
Herrin, A.N., Huq, N., Ibragimova, S., Karan, A., Lee, T.J., Leung, G.M., Lu, J.F.R.,
Research, 7(200), 1-6.
Ng, K.Y.A., Pande, B.R., Racelis, R., Tao, S., Tin, K., Trisnantoro, L., Vasavid, C., Yang, B.M. & Zhao, Y. (2007). Catastrophic payments for health care in Asia. Health
Bont, A.A. de, Zandwijken, G., Stolk, E.A. & Niessen, L.W. (2007). Prioritisation by
Economics, 16(11), 1159-1184.
physicians in the Netherlands The growth hormone example in drug reimbursement decisions. Health Policy, 80, 369-377.
O’Donnell, O., Doorslaer, E.K.A. van, Rannan-Eliya, R.P., Somanathan, A., Adhikari, S.R., Harbianto, D., Garg, C.C., Hanvoravongchai, P., Huq, N., Karan, A.,
Bree, R. de, Putten, L. van der, Hoekstra, O.S., Kuik, D.J., Groot, C.A. de, Tinteren,
Leung, G.M., Wan Ng, C., Raj Pande, B., Tin, K., Tisayaticom, K., Trisnantoro, L.,
H. van, Leemans, C.R. & Boers, M. (2007). A randomized trial of PET scanning to
Zhang, Y. & Zhao, Y. (2007). The Incidence of Public Spending on Healthcare:
improve diagnostic yield of direct laryngoscopy in patients with suspicion of
Comparative Evidence from Asia. The World Bank Economic Review, 21, 93-123.
recurent laryngeal carcinoma after radiotherapy. Contemporary Clinical Trials, 28, 705-712.
Exel, N.J.A. van, Graaf, G. de & Brouwer, W.B.F. (2007). Care for a break? An investigation of informal caregivers' attitudes toward respite care using
Bree, R. de, Reith, R., Quak, J.J., Groot, C.A. de, Agthoven, M. van & Leemans, C.R.
Q-methodology. Health Policy, 83, 332-342.
(2007). Free radial forearm flap versus pectoralis major myocutaneous flap
30
reconstruction of oral and oropharyngeal defects: a cost analysis. Clinical
Exel, N.J.A. van, Bobinac, A., Koopmanschap, M.A. & Brouwer, W.B.F. (2007).
Otolaryngology, 32, 275-282.
Providing informal care: a burden and a blessing. Health and Ageing, 16, 10-13.
Brouwer, W.B.F., Exel, N.J.A. van, Baal, P. & Polder, J. (2007). Economics and
Galani, C.M., Schneider, H. & Rutten, F.F.H. (2007). Modelling the lifetime costs
public health: Engaged to be happily married! European Journal of Public
and health effects of lifestyle intervention in the prevention and treatment of
Health, 17(2), 122-123.
obesity in Switzerland. International Journal Public Health, 52, 1-11.
Cohen, J., Panquette, A.B. & Cairns, C. (2007). Can Medicare Draw Lessons From
Goor, K.M., Peeters, A.J.G.E., Mahieu, H.F., Langendijk, J.A., Leemans, C.R.,
Dutch Experience With a National Formulary? Medical Information, 41, 257-272.
Verdonck, I.M. & Agthoven, M. van (2007). Cordectomy by Co2 laser or
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
radiotherapy for small T1a glottic carcinomas: costs, local control, survival,
Koopmans, G.T. & Lamers, L. (2007). Gender and health care utilization: The role
quality of life, and voice quality. Head & Neck-Journal for the Sciences and
of mental distress and help-seeking propensity. Social Science & Medicine, 64,
Specialties of the Head and Neck, 128-136.
1216-1230.
Gravelle, H., Brouwer, W.B.F., Niessen, L.W., Postma, M. & Rutten, F.F.H. (2007).
Krol, H.M., Koopman, M.I., Uyl-de Groot, C.A. (2007). A systematic review of
Discounting in economic evaluations: stepping forward towards optima
economic analyses of pharmaceutical therapies for advanced colorectal cancer.
decision rules. Health Economics, 16, 307-317.
Expert Opinion on Pharmacotherapy, 8, 1313-1328.
Hakkaart-van Roijen, L., Zwirs, B.W.C., Bouwmans, C.A.M., Tan, S.S., Schulpen,
Lai, T., Habicht, J., Reinap, M., Chrisholm, D. & Baltussen, R.M.P.M. (2007). Costs,
T.W.J., Vlasveld, L. & Buitelaar, J.K. (2007). Societal costs and quality of life of
health effects and cost-effectiveness of alcohol and tobacco control strategies
children suffering from attention deficient hyperactivity disorder (ADHD).
in Estonia. Health Policy, 84, 75-88.
a
a
a
a
a
a
a
European Child & Adolescent Psychiatry, 16(5), 316-326.
Hart, H.E., Redekop, W.K., Bilo, H.J.G., Meyboom-de Jong, B. & Berg, M. (2007). Health related quality of life in patients with type I diabetes mellitus: generic & disease-specific measurement. Indian Journal of Medical Research, 125, 203-216.
Horn, E.K., Benthem, T.B. van, Hakkaart-van Roijen, L. , Marwijk, H.W.J. van, Beekman, A.T.F., Rutten, F.F.H. & Feltz-Cornelis, C.M. van der (2007). Costeffectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting a randomised controlled trial. BMC Health Services Research, 7(28), 1-14.
Hurdle, J.F., Adams, S.A., Brokel, J., Chang, B., Embi, P.J., Petersen, C., Terrazas, E. & Winkelstein, P. (2007). A Code of Professional Ethical Conduct for the American Medical Informatics Association: an AMIA Board of Directors Approved White Paper. JAMIA Journal of the American Medical Informatics Association, 14(4), 391-393.
IJff, M.A., Huijbregts, K.M.L., Marwijk, H.W.J. van, Beekman, A.T.F., Hakkaart-van Roijen, L., Rutten, F.F.H., Unutzer, J. & Feltz-Cornelis, C.M. van der (2007). Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomise clinical trial. BMC Health Services Research, 7(34), 1-11.
Jansen, E., Baltussen, R.M.P.M., Doorslaer, E.K.A. van, Ngirwamungu, E., Ngygen, M.P. & Kilima, P. (2007). An eye for inequality: how trachoma relates to poverty in Tanzania and Vietnam. Ophthalmic Epidemiology, 200(14), 278-287.
Lamers, L.M., Groot, C.A. de & Buijt, I. (2007). The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis. PharmacoEconomics, 25(7), 591-603.
Jansen, Y.J.F.M., Bont, A.A. de, Foets, M.M.E., Bruijnzeels, M.A. & Bal, R. (2007). Tailoring intervention procedures to routine primary health care practice: an
Lintsen, A.M.E., Eijkemans, M.J.C., Hunault, C.C., Bouwmans, C.A.M., Hakkaart-
ethnographic process evaluation. BMC Health Services Research, 7(125), 1-8.
van Roijen, L., Habbema, J.D.F. & Braat, D.D.M. (2007). Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Human
Jones, A.M., Koolman, A.H.E. & Doorslaer, E.K.A. van (2007). The impact of
Reproduction, 22(9), 2455-2462.
having supplementary private health insurance on the use of specialists. Annales d'Economie et de Statistique, 83/84, 1-25.
Lu, J.F.R., Leung, G.M., Kwon, S., Tin, K.Y.K , Doorslaer, E.K.A. van & O’Donnell, O. (2007). Horizontal equity in health care utilization evidence from three highincome Asian economies. Social Science & Medicine, 64, 199-212.
31
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Niessen, L.W., Grijseels, E.W.M., Koopmanschap, M.A. & Rutten, F.F.H. (2007).
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Book (chapter)
Economic analysis for clinical practice - the case of 31 national consensus guidelines in the Netherlands. Journal of Evaluation in Clinical Practice, 13(1), 68-78.
Adams, S.A. & Boot, C.R.L. (2007). Gewoon digitaal. In J. Steyaert & J. de Haan (Eds.), Jaarboek ICT en samenleving 2007 (pp. 189-10). Amsterdam: Boom.
Niezen, M.G.H., Bont, A.A. de, Stolk, E.A., Eyck, A., Niessen, L.W. & Stoevelaar, H. (2007). Conditional reimbursement within the Dutch drug policy. Health Policy,
Bekker, M.P.M., Wallenburg, I. & Helderman, J.K. (2007). Verschuivende
84, 39-50.
verhoudingen: de marges van overheidsbeleid bij overgewicht. In Dagevos H. & Munnichs G. (Eds.), De Obesogene samenleving Maatschappelijke perspectieven
Pirnejad, H., Bal, R., Stoop, A.P. & Berg, M. (2007). Inter-organisational
op overgewicht (pp. 155). Amsterdam: Amsterdam University Press.
communication networks in healthcare: centralised versus decentralised approaches. International Journal of Integrated Care, 7, 1-12.
Buijsen, M.A.J.M. (2007). Actieve levensbeëindiging bij ernstig lijdende pasgeborenen in Nederland. In W.J M. Eijk, R. Stockman & J.A. Raymakers (Eds.),
Poel van de, E., O’Donnell, O., Doorslaer, E.K.A. van (2007). Are urban children
Kwaliteit van Leven in Christelijk Perspectief (pp. 93-6). Gent: Canon Triest.
really healthier? Evidence from 47 developing countries, Social Science and Medicine, 65(10),1986-2003
Buijsen, M.A.J.M. (2007). Notities van zelfbeschikking. In R. Janse, S. Teakema & T. Hol (Eds.), Rechtsfilosofische annotaties (pp. 114-7). Nijmegen: Ars Aequi Libri.
Poleij, M.J., Edelenbos, K.I., Mosseveld, B.M.T., Wijk, M.A.M. van, Bakker, D.H. de, Lei, J., Rutten-van Mölken, M.P.M.H. (2007). Cost consequences of implemen-
Buijsen, M.A.J.M. (2007). Wet- en regelgeving in de zorg Bijzondere patiënten-
ting an electronic decision support system for ordering laboratory tests in
rechten in de gezondheidszorg. Eindhoven: SBO.
primary care: Evidence from a controlled prospective study in the Netherlands. Clinical Chemistry, 53(2), 213-219.
Brouwer, W.B.F. & Rutten, F.F.H. (2007). Zorgverzekeringen: een centraal gezondheidsonderzoeksgebied. In Handboek gezondheidszorgonderzoek
Rutten-van Mölken, M.P.M.H., Nooten, F.E. van, Lindemann, M., Caeser, M. &
(pp. 208-17). Bohn Stafleu van Loghum.
Calverley, P.M.A. (2007). A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patient. PharmacoEconomics, 25(8), 695-711.
Dijstelbloem, H., Meurs, P.L. & Schrijvers, E.K. (2007). Maatschappelijke dienstverlening. Een onderzoek naar vijf sectoren. Amsterdam: Amsterdam
Rutten-van Mölken, M.P.M.H., Oostenbrink, J.B., Miravitlles, M. & Monz, B.U.
University Press.
(2007). Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in
O’Donnell, O., Doorslaer, E.K.A. van, Wagstaff, A. & Lindelow, M. (2007).
Spain. European Journal of Health Economics (HEPAC), 8, 123-135.
Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation. Washington DC: World Bank 2007.
Sendi, P., Brouwer, W.B.F., Bucher, H.C., Weber, R. & Battegay, M. (2007). When time is more than money: The allocation of time between work and leisure in
Foets, M.M.E., Suurmond, J. & Stronks, K. (2007). De relatie tussen etnische
HIV-infected patients. Social Science & Medicine, 64, 2355-2361.
herkomst en gezondheidszorg. Een conceptualisering. In M.M.E. Foets, J. Schuster & K. Stronks (Eds.), Gezondheids(zorg)onderzoek onder allochtone
Stoop, A.P., Bal, R. & Berg, M. (2007). OZIS and the politics of safety: Using ICT to
bevolkingsgroepen een praktische introductie (pp. 29). Amsterdam: Askant.
create a regionally accessible patient medication record. International Journal of Medical Informatics, 76S, S229-S235.
Foets, M.M.E. (2007). Crossculturele validiteit. Spanning tussen theorie en praktijk. In M.M.E. Foets, J. Schuster & K. Stronks (Eds.), Gezondheids(zorg)-
Tan, S.S., Groot, C.A. de, Huijgens, P.C. & Fibbe, W.E. (2007). Stem cell
onderzoek onder allochtone bevolkingsgroepen een praktische introductie
transplantation in Europe: trends and prospects. European Journal of Cancer,
(pp. 77). Amsterdam: Askant.
43, 2359-2365. Foets, M.M.E. (2007). Steekproeftrekking identificatie van de allochtone Zuiderent-Jerak, T. & Jensen, C.B. (2007). Editorial Introduction: Unpacking
populatie. In M.M.E. Foets, J. Schuster & K. Stronks (Eds.), Gezondheids(zorg)-
'Intervention' in Science and Technology Studies. Science as Culture, 16(3),
onderzoek onder allochtone bevolkingsgroepen een praktische introductie
227-235.
(pp. 53). Amsterdam: Askant.
Polder, J., Baal, P., Exel, N.J.A. van & Brouwer, W.B.F. (2007). Preventie: niet altijd goedkoop, wel vaak een goede koop. Een economisch verhaal over preventie en
32
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
de waarde van gezondheid. In Jaarboek Publieke Gezondheid (pp. 128-3).
Buijsen, M.A.J.M. (2007). Verdere decriminalisering euthanasie ongewenst.
Abcoude: Stichting Public Health Forum.
Nederlands Juristenblad (NJB), 32, 2027-2028.
Polder, J.J., Baal, P.H.M., Exel, N.J.A. van & Brouwer, W.B.F. (2007). Een econo-
Dwarswaard, J. & Hilhorst, M. (2007). Zorgvernieuwing, vrouwen en reclame.
misch verhaal over preventie en de waarde van gezondheid. In Jaarboek
VAMP, 35, 2-4.
a
a
a
a
a
a
a
a
a
Publieke Gezondheid 2007 (pp. 128-3). Abcoude: Stichting Public Health Forum. Dwarswaard, J., Hilhorst, M. & Trappenburg, M.J. (2007). Toch maar liever Rutten, F.F.H. & Brouwer, W.B.F. (2007). Economische evaluaties in de
timmerman? In J. Kole & D. de Ruyter (Eds.), Werkzame Idealen Etnische
gezondheidszorg. In T. Ploch, R.E. Juttmann, N.S. Klazinga & J.P. Mackenbach
reflecties op professionaliteit (pp. 37-4).
(Eds.), Handboek gezondheidszorgonderzoek (pp. 132-10). Bohn Stafleu van Loghum.
Dwarswaard, J., Hilhorst, M.T. & Trappenburg, M.J. (2007). Is er een dokter in de zaal? Filosofie en Praktijk, 28(5), 6-19.
Article in Dutch journal
Egmond, C. van, Bekker, M.P.M., Bal, R. & Grinten, T.E.D. van der (2007). De Volksgezondheid Toekomst Verkenning als infrastructuur voor evidence-based
Brouwer, W.B.F., Exel, N.J.A. van & Baal, P. (2007). De kosten in gewonnen
gezondheidsbeleid. TSG, 85(7), 399-406.
levensjaren - tijd voor een nieuwe richtlijn! VGE Bulletin, 24(1), 11-14. Koopmanschap, M.A. & Steenhoek, A. (2007). Kosten voor dure medicijnen Bekker, M.P.M. (2007). Welles/Nietes Wetenschap kan de politiek van gezond
rijzen de pan uit. Groter gebruik: lagere prijs. PW, 142, 1-1.
beleid niet vervangen. G vakblad over gezondheid en maatschappij, 23, 5. Polder, J.J. & Brouwer, W.B.F. (2007). Een mistroostige wetenschap? TSG, 85(4), Bos, T. van den, Visser-Meily, A. & Exel, N.J.A. van (2007). Optimalisering van
202-204.
zorg aan CVA patiënten in de huisartsenpraktijk. Huisarts en Wetenschap, 50, 552-556.
Rutten, F.F.H. & Brouwer, W.B.F. (2007). "Value for money" in de zorg; geen woorden maar daden. M&O, 61, 171-179.
Brouwer, W.B.F. & Stolk, E.A. (2007). De grenzen van het pakket. IKR-bulletin (Rotterdam), 31, 22-23.
Steenhoek, A. (2007). Dure geneesmiddelen: waait ook nu de bui weer over? IKR-bulletin (Rotterdam), 31, 4-5.
Brouwer, W.B.F. & Polder, J.J. (2007). Gereguleerde concurrentie: broodnodig. Tien woorden gezondheidseconomie. TSG, 85(8), 417-422.
Steenhoek, A. (2007). Patiënt krijgt zwartepiet. Pharmaceutisch Weekblad, 142, 1-1.
Brouwer, W.B.F. & Polder, J. (2007). Nuttige verzekering: Het verhaal van Kees, Truus, Bert & Bertine en Al. TSG, 85(6), 303-305.
Trappenburg, M.J. & Dwarswaard, J. (2007). Rolconflicten. Huisarts en Wetenschap, 50(10), 512-513.
Buijsen, M.A.J.M. (2007). De euthanasieweg geëvalueerd. Journaal Privacy Gezondheidszorg, 8, 107-109.
Uyl-de Groot, C.A. & Steenhoek, A. (2007). Nieuwe 'dure' kankergeneesmiddelen en kosteneffectiviteitsanalyses: hoe is de stand van zaken?
Buijsen, M.A.J.M. (2007). De Euthanasieweg geëvalueerd: enkele kritische
IKR-bulletin (Rotterdam), 31, 28-30.
kanttekeningen. Ars Aequi, 56(9), 669-672.
Buijsen, M.A.J.M. (2007). De evaluatie van de Euthanasieweg: een verkapt
Research Line: Health care management
pleidooi voor normalisering van de euthanasiepraktijk. TGE. Tijdschrift voor Gezondheidszorg & Ethiek, 17(4), 94-98.
Article/Letter to the editor
Buijsen, M.A.J.M. (2007). De normatieve grondslagen van het Nederlandse
Aarts, J.E.C.M., Ash, J. & Berg, M. (2007). Extending the understanding of
euthanasierecht. Pro Vita Humana, 3, 60-64.
computerized physician order entry: Implications for professional collaboration workflow and quality of care. International Journal of Medical Informatics,
Buijsen, M.A.J.M. (2007). Esther Pans, De normatieve grondslagen van het
76S, 4-13.
Nederlandse euthanasierecht. Rechtsgeleerd Magazijn Themis, 168(2), 72-75.
33
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Aarts, J.E.C.M. & Gorman, P. (2007). IT in health care: sociotechnical approaches
different reading and referral strategies in mammography screening in the
"To Err is System". International Journal of Medical Informatics, 76S, S1-S3.
Netherlands. Breast Cancer Research and Treatment, 102(2), 211-218.
Aarts, J.E.C.M. (2007). Letter to the editor. Methods of Information in
Minkman, M., Ahaus, K. & Huijsman, R. (2007). Performance improvement based
Medicine, 1.
on integrated quality management models: what evidence do we have?
a
A systematic literature review. International Journal for Quality in Health Care, Bijlenga, D., Birnie, E., Mol, B.W.J. & Bonsel, G.J. (2007). When outcome is a
19(2), 90-104.
balance: methods to measure combined utility for the choice between induction of labour and expectant management in mild risk pregnancy at
Mul, M. de & Berg, M. (2007). Completeness of medical records in emergency
term. BioMed Central, 7, 1-4.
trauma care and an IT-based strategy for improvement. Medical Informatics and the Internet in Medicine, 32, 157-167.
Boers, K.E., Bijlenga, D., Mol, B.W.J., Cessie, S. le, Birnie, E., Pampus, M.G. van, Stigter, R.H., Bloemenkamp, K.W.M., Meir, C.A. van, Post, J.A.M. van der,
Mul, M. de, Bont, A.A. de & Berg, M. (2007). It-Supported skill-mix change and
Bekedam, D.J., Ribbert, L.S.M., Drogtrop, A.P., Salm, P.C.M. van der, Huisjes,
standardisation in integrated eyecare: lessons from two screening projects in
A.J.M., Willekes, C., Roumen, F.J.M.E., Scheepers, H.C.J., Boer, K. de, Duvekot, J.J.,
The Netherlands. International Journal of Integrated Care, 7, 1-10.
Thornton, J.G. & Scherjon, S.A. (2007). Disproportionate intrauterine growth intervention trial at term: DIGITAT. BMC Pregnancy and Childbirth, 7, 1-12.
Pickard, A.S., Kohlmann, T., Janssen, M.F., Bonsel, G.J. & Cella, D. (2007). Evaluating equivalency between response systems. Medical Care, 45(9), 812-819.
Boot, H.J., Wallenburg, I., Melker, H.E. de, Mangen, M.M., Gerritsen, A.A.M., Maas, N.A., Berkhof, J. Meijer, C.J.L.M. & Kimman, T.G. (2007). Assessing the
Scheer, W.K. van der (2007). Is the new health-care executive an entrepreneur?
introduction of universal human papillomavirus vaccination for preadolescent
Public Management Review, 9(1), 49-65.
girls in the Netherlands. Vaccine, 25, 6245-6256. Steinbusch, P.J.M., Oostenbrink, J.B., Zuurbier, J.J. & Schaepkens, F.F.J.M. (2007). Christiaans, I., Dijksman, L.M. & Birnie, E. (2007). ESCAPE-HCM study: Evaluation
The risk of upcoding in casemix systems: A comparative study. Health Policy, 81,
of Screening of Asymptomatic patients with hypertrophic CardioMyopathy.
289-299.
Netherlands Heart Journal, 15(6), 216-220. Steuten, L., Lemmens, K.M.M. & Vrijhoef, B. (2007). Health technology assessment Dirks, M., Niessen, L.W., Huijsman, R., Wijngaarden, J.D.H. van, Minkman,
of asthma disease management programs. Current Opinion in Allergy and Clinical
M.M.N., Franke, C.L., Oostenbrugge, R.J. van, Koudstaal, P.J. & Dippel, D.W.J.
Immunology, 7, 242-248.
(2007). Promoting acute thrombolysis for ischaemic stroke (PRACTISE). International Journal of Stroke, 2, 151-159.
Strating, M.M.H., Schuur, W.H. van, Suurmeijer, T.P.B.M. (2007). Predictors of functional disability in rheumatoid arthritis: results from a 13-year prospective
Essink-Bot, M.L., Stuifbergen, M.C., Meerding, W.J., Looman, C.W.N. & Bonsel,
study. Disability and Rehabilitation, 29(10), 805-15.
G.J. (2007). Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study. BMC Health
Strating, M.M.H., Duijn, M.A.J., Schuur, W.H. van & Suurmeijer, T.P.B.M.
Services Research, 7.
(2007). The differential effects of rheumatoid arthritis on distress among patients and partners. Psychology and Health, 22(3), 361-379.
Finkenflügel, H.J.M. (2007). Changing roles of physical therapists in community-based rehabilitation. Physical Therapy, 117(3), 74-75.
Tielen, M., Staa, A.L. van, Jedeloo, S. & Weimar, W. (2007). Q-methodology to identify young renal transplant recipients at risk for non-compliance.
Glind, I.M. van de, Roode, S. & Goossensen, M.A. (2007). Do Patients in hospitals
Transplantationsmedizin, 19, 61-62.
benefit from single rooms? A literature review. Health Policy, 84, 153-161. Valentine, N.B., Bonsel, G.J. & Murray, C.J.L. (2007). Measuring quality of health care Goossensen, M.A., Zijlstra, P. & Koopmanschap, M.A. (2007). Measuring shared
from the user's perspective in 41 countries: psychometric properties of WHO's
decision making processes in psychiatry: Skills versus patient satisfaction.
questions on health systems responsiveness. Quality of Life Research, 16, 1107-1125.
Patient Education and Counseling, 67, 50-56. Vissers, J.M.H., Adan, I.J.B.F. & Dellaert, N.P. (2007). Developing a platform for
34
Groenewoud, A.S., Otten, J.D.M., Fracheboud, J., Draisma, G., Ineveld, B.M. van,
comparison of hospital admission systems: an illustration. European Journal of
Holland, R., Verbeek, A.L.M. & Koning, H.J. de (2007). Cost-effectiveness of
Operational Research, 3, 1290-1301.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Vries, J. de, Commandeur, H. & Huijsman, R. (2007). Management en
Weggelaar-Jansen, J.W.M., Akkersdijk, H., Waegemaekers, H. & Grim, R. (2007).
Organisatie in de gezondheidszorg. M&O, 61(2), 5-21.
Leren veranderen Bespreking van het boek 'Leren veranderen'. Een handboek
a
a
a
a
a
a
a
a
voor de veranderkundige. Zorgmarkt, 2, 38-39. Wijngaarden, J.D.H. van, Bont, A.A. de & Huijsman, R. (2007). Learning to cross boundaries: The integration of a health network to deliver seamless care. Health Policy, 79(2-3), 203-213.
Article in Dutch journal
Zuiderent-Jerak, T. (2007). Preventing Implementation: Exploring Interventions
Bal, R. (2007). De bevlogen onderzoeker. Kwaliteit in beeld, 17(2), 6-7.
with Standardization in Healthcare. Science as Culture, 16(3), 311-329. Bal, R. & Pijnenborg, L. (2007). Sneller Beter Pijler 3 Een tussenstand. ZE magazine, 1(2), 28-33.
Book (chapter) Cramm, J.M., Finkenflügel, H.J.M. & Brinkman, A. (2007). Palliatieve dagzorg; Goossensen, M.A., Arts, K. & Beltman, M.A.C. (2007). 'Mij mankeert niks'.
een nieuw zorgconcept in Nederland. Nederlands Tijdschrift voor Palliatieve
In Zorgprogramma Korsakov in het verpleeghuis. Rotterdam: Korsakov
Zorg, 8(2), 43-46.
Kenniscentrum. Dijk, J.K. van, Paauwe, P. & Wijk, K.P. van (2007). Arbeidsmarkt, personeel en Huijsman, R. (2007). Rijkere perspectieven op uw zorggebouw. Het pand als
innovatie. ZE magazine, 03, 8-12.
bedrijfsinstrument in het serviceconcept van de maatschappelijk zorgondernemer. In AU! Bouwen aan de architectuur van de zorg (pp. 118).
Finkenflügel, H.J.M. (2007). In 2015 is de WMO alweer verleden tijd. Zorg +
Utrecht: College bouw zorginstellingen.
Welzijn, 13, 24.
Scholten, G.R.M., Wijngaarden, J.D.H. van & Wijk, K.P. van (2007).
Geelhoed, J., Reijmerink, W. & Goeij, H. de (2007). Sneller en beter verbinden
Zorgmanagers en hun gereedschapskist de toepassing van de Swot in de
van kennis en opvattingen voor een gezondere samenleving. Forum, 85(2),
gezondheidszorg. In J. de Vries, H. Commandeur & R. Huijsman (Eds.), M&O
70-75.
(pp. 146). Deventer: Kluwer. Goossensen, M.A., Glind, G. van de, Carpentier, P.J., Wijsen, R.M.A., Duin, D. van Staa, A.L. van, Jedeloo, S., Kuijper, M., Latour, J. (2007). Op Eigen Benen.
& Kooij, S. (2007). Herkenning en intramurale behandeling van ADHD in de
Jongeren met chronische aandoeningen; wat willen en kunnen zij in de zorg?
verslavingszorg. Verslaving, 3(4), 18-30.
Rotterdam, Hogeschool Rotterdam, Kenniskring Transities in Zorg. Goossensen, M.A. (2007). Veranderen en vernieuwen in de verslavingszorg (1): Stoopendaal, A.M.V. (2007). Afstand en nabijheid, een reactie. Vibes, 8.
over blauwe en witte mensen. Verslaving, 3, 68-70.
Stoopendaal, A.M.V. & Kröber, H. (2007). De aanwezige professional. In Lef en
Goossensen, M.A. (2007). Veranderen en vernieuwen in de verslavingszorg (2):
Liefde in de Zorg: Nieuwe impulsen voor het werk van professionals en
over kwaliteit van aandacht. Verslaving, 3, 77-78.
managers in de zorg (pp. 47). Rotterdam: Zorgpodium. Goossensen, M.A. (2007). Veranderen en vernieuwen in de verslavingszorg (3): Tielen, M., Jedeloo, S., Staa, A.L. van, Weimar, W. (2007) Immunosuppressive
de verborgen kracht van mentale modellen. Verslaving, 3(4), 64-65.
Drugs and Young Adults: A difficult combination. In Weimar, W. Bos, M.A., Busschbach, J.J. van (Eds.), Organ Transplantation: Ethical, Legal and Psycho-
Hiddema, U.F., Korne, D.F. de, Sol, K., Vingerhoets, A.J.J.M. & Smolderen, K.G.E.
social Aspects. Towards a Common European Policy. Lengerich (Germany),
(2007). Don't worry, get healthy! Angstreductie als centrale bedrijfsfilosofie in
PABST Science Publishers, 555–561.
een ziekenhuis. Kwaliteit in beeld, 5, 13-15.
Vries, J. de, Commandeur, H. & Huijsman, R. (2007). Overzicht en Reflectie. In J.
Hout, E. van, Scheer, W.K. van der & Putters, K. (2007). Managers en
de Vries, H. Commandeur & R. Huijsman (Eds.), M&O (pp. 146). Deventer: Kluwer.
professionals in de zorg: over verschuivende verantwoordelijkheden en hybridisering. Bestuurskunde, 16(4), 16-24.
Weggelaar-Jansen, J.W.M. (2007). Implementatie: effectieve verbetering van de patiëntenzorg Bespreking van het boek Implementatie: effectieve verbetering
Huijsman, R. (2007). Borg innovatie. Kwaliteit in beeld, 4, 12-12.
van de patiëntenzorg. Kwaliteit in beeld, 23-23.
35
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Huijsman, R. (2007). Care op kruispunt. Kwaliteit in beeld, 3, 6-6.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Staa, A.L. van, Kuijper, M., Jedeloo, S. & Latou, J.M. (2007). Participatie van jongeren in de spreekkamer Hoe kunnen kinderverpleegkundigen jongeren
Huijsman, R. (2007). Het pand als bedrijfsinstrument. Het totale serviceconcept
met chronische aandoeningen activeren? Tijdschrift Kinderverpleging, 13, 10-13.
van de maatschappelijk zorgondernemer. ZM Magazine, 23(10), 4-8. Staa, A.L. van, Jedeloo, S., Kuijper, M. & Latour, J.M. (2007). Op Eigen Benen. Huijsman, R. & Pol, B. (2007). In het verpleeghuis is het veilig. Ouderen huiverig
Jongeren met chronische aandoeningen: wat willen en kunnen zij in de zorg?
voor zelfstandige groepswoningen. ZorgVisie (Maarssen), 8, 14-16.
In Bessensap (pp. 8). NWO.
Huijsman, R. (2007). Management en organisatie in de gezondheidszorg.
Stoopendaal, A.M.V. & Kröber, H. (2007). Wie presentie zaait zal presentie
Kwaliteit in beeld, 4, 17-18.
oogsten. ZM Magazine, 23, 2-5.
Huijsman, R. (2007). Module geïntegreerde eerstelijnszorg: expliciteren en
Vissers, J.M.H., Roosenschoon, B.J., Eijk, J. van der & Veen, H. de (2007).
contracteren van prestaties. LVG Nieuws, 3, 22-23.
Patiëntendoorstroming in een GGZ-instelling: een logistieke benadering. ZM Magazine, 3, 12-16.
Huijsman, R. (2007). Ruimte voor bevlogen professionals. Kwaliteit in beeld, 2, 9-9.
Vissers, J.M.H. (2007). Zorglogistiek en Operations Research. Het nut van modellen. ZE magazine, 2, 18-23.
Huijsman, R. (2007). Toezicht: laveren tussen kunde en kitsch. Kwaliteit in beeld, 1, 11-11.
Vries, G. de (2007). Normering als instrument voor processturing. Meet- en regeltechniek in de zorgsector. M&O, 2, 22-35.
Huijsman, R. (2007). Zorgbouw als opbrengstengenerator. Kwaliteit in beeld, 5, 7-7.
Vries, G. de (2007). Zorglogistiek definitief op de kaart. Na dertig jaar langzaam uit de kinderschoenen. ZE magazine, 2, 8-13.
Korne, D.F. de, Hiddema, U.F., Bleeker, F.G. & Dyck, C. van (2007). Versterking veiligheidscultuur door multidisciplinaire teamtraining. Kwaliteit in beeld, 6, 7-10.
Weggelaar-Jansen, J.W.M., Wijngaarden, J.D.H. van & Bal, R. (2007). Leren verbeteren - verbeterd leren. Leren in een quality collaborative in Nederlandse
Nas, W.S.C., Stege, H.A. van der, Jedeloo, S. & Staa, A.L. van (2007). Een roos-
ziekenhuizen. M&O, 6, 48-64.
kleurig beeld: Kwaliteit van leven van jongeren met chronische aandoeningen onderzocht in "Op Eigen Benen Verder". Verpleegkunde, 22(4), 203-203.
Wijk, K.P. van (2007). Recentie van "The Oxford Handbook of Human Resource Management". ZE magazine, 03, 44-44.
Scholten, G.R.M. & Jacques, D.R. (2007). Onzichtbaar zorgmanagement. M&O, 2, 160-170.
Zijlstra, P. & Goossensen, M.A. (2007). Shared Decision Making in de psychiatrie. TSG, 2(85), 92-97.
Schuppen, M.T. van, Finkenflügel, H.J.M. & Gardenbroek, R. (2007). Anticonceptiezorg in de eerstelijns praktijk? Tijdschrift voor Verloskundigen, 32(2), 13-16.
Snoeren, M.C.W., Dekker-van Doorn, C.M. (2007). Leren = Veranderen. Een kwalitatief onderzoek naar de relatie tussen veranderingsprocessen en de leerstrategie van lageropgeleide medewerkers, Verpleegkunde, 22, pp 86-97.
Staa, A.L. van (2007). Een volwassen leven met Congenitale Ano-Rectale Misvormingen (CARM) tot tell or not to tell. Verpleegkunde, 22(4), 201-201.
Staa, A.L. van (2007). Jongeren doen zorgonderzoek in de disco. Mediator, 18, 30-32.
Staa, A.L. van (2007). Observaties van jongeren met een chronische aandoening op de polikliniek: van toeschouwer naar hoofdpersoon. Verpleegkunde, 22(4), 202-202.
36
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
37
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Academic publications 2008
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Hassink, W.H.J. & Schut, F.T. (2008). Price competition in border and non-border areas: the case of the Dutch market of gasoline retailers. Applied Economics Quaterly, 54(2), 95-122.
Kleef, R.C. van, Beck, K., Ven, W.P.M.M. van de & Vliet, R.C.J.A. van (2008). Risk equalization and voluntary deductibles: A complex interaction. Journal of Health Economics, 27, 427-443.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Varkevisser, M., Capps, C.S. & Schut, F.T. (2008). Defining hospital markets for antitrust enforcement: new approaches and their applicability tot
Research line: Competition and regulation in health care
The Netherlands. Health Economics Policy and Law, 3, 7-29.
Ven, W.P.M.M. van de & Schut, F.T. (2008). Universal mandatory health
Article/Letter to the editor
insurance in The Netherlands: a model for The United States? Health Affairs, 27(3), 771-781.
Abdellaoui, M., Bleichrodt, H. & l'Haridon, O. (2008). A Tractable Method to Measure Utility and Loss Aversion under Prospect Theory. Journal of Risk and Uncertainty 36, 245-266.
Book (chapter)
Akveld, J.E.M. & Buijsen, M.A.J.M. (2008). Een gemiste kans. Het kabinetsstand-
Buijsen, M.A.J.M. (2008). Over artsen en hun autonomie. In Vincent Kirkels (Ed.),
punt inzake orgaandonatie. Journaal Privacy Gezondheidszorg, 9(8), 195-199.
Oude idealen in de nieuwe zorgmarkt (Annalen van het Thijmgenootschap, 1) (pp. 24-52). Nijmegen: Valkhof Pers.
Akveld, J.E.M. & Buijsen, M.A.J.M. (2008). Het kabinetsstandpunt masterplan orgaandonatie kritisch bezien. Zorg & Financiering, 8, 26-34.
Buijsen, M.A.J.M. (2008). The meaning of 'Justice' and 'Solidarity' in health care. In A.P. den Exter (Ed.), International Health Law. Apeldoorn: Maklu.
Berg, B. van den, Dommelen, P. van, Stam, P.J.A., Laske-Aldershof, T., Buchmueller, T. & Schut, F.T. (2008). Preferences and choices for care and health
Buijsen, M.A.J.M. (2008). The meaning of 'Justice' in health care. In A.P. den
insurance. Social Science & Medicine, 66(12), 2248-2459.
Exter (Ed.), International Health Law (pp. 535-546). België: Maklu.
Berg, B van den, Dommelen, P. van, Stam, P.J.A., Laske-Aldershof, T. & Schut, F.T.
Essers, M.J.J.M., Hermans, H.E.G.M. & Sluijs, J.J.M. (2008). Aanbesteden en
(2008). Preferenties en keuzen voor zorg en zorgverzekeraars. TSG, 86(1), 39-46.
mededinging in de gezondheidszorg. Houten: Bohn Stafleu van Loghum.
Boonen, L.H.H.M., Schut, F.T. & Koolman, A.H.E. (2008). Consumer channeling
Exter, A.P. den (2008). Litigating health care access in the Netherlands.
by health insurers: natural experiments with preferred providers in the Dutch
In A.P. den Exter (Ed.), International Health Law. Apeldoorn: Maklu.
pharmacy market. Health Economics, 299-316. Exter, A.P. den & Prudil, L. (2008). The Czech Republic. In R. Blanpain & H. Nys Buijsen, M.A.J.M. (2008). Assisted Suicide and Euthanasia. A Natural Law Ethics
(Eds.), International Encyclopaedia of Laws. Canada: Kluwer Law International.
Approach. Medical Health Care and Pilosophy, 11, 1-1. Grit, K. Boekbespreking (2008). Genoeg is genoeg. Over gezondheidszorg en Dijk, M. van, Pomp, M., Douven, R., Laske-Aldershof, T., Schut, F.T., Boer, W. de
democratie. Trappenburg, M.J. Medische Antropologie, 20(2), 378-380.
& Boo, A. de (2008). Consumer price sensitivity in Dutch health insurance. International Journal of Health Care Finance and Economics, 8, 225-244.
Halffman, W., Bal, R., (2008). After impact. Success of scientific advice to public policy. In States of Nature, edited by W. Halffman. Den Haag: RMNO
Exter, A.P. den (2008). Claiming access to health care in the Netherlands under international treaty law. Medicine and Law, 27, 569-595.
Hermans, H.E.G.M. & Windhorst, C.J. (2008). Tekst en toelichting Wet toelating zorginstellingen. In Tekst en toelichting Wet toelating zorginstellingen. Den
Exter, A.P. den (2008). Editorial: Access to Health Care Solidarity and Justice. Medicine and Law, 27, 1-5.
38
Haag: Sdu Uitgevers.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Hermans, H.E.G.M. & Windhorst, C.J. (2008). Wet toelating zorginstellingen.
Schut, F.T. & Varkevisser, M. (2008). Garanties voor mededinging.
In Wet toelating zorginstellingen. Den Haag: Sdu Uitgevers.
Fusiedrang bedreigt ontluikende marktwerking. Zorgvisie Magazine, 11.
Ven, W.P.M.M. van de (2008). A competitive market for social health insurance
Schut, F.T. & Roos, A.F. (2008). Risico's van koppeling basis- en aanvullende
in five countries: is there a relation between funding and organizing health
zorgverzekering. Economisch Statistische Berichten, 93, 710-713.
a
a
a
a
a
a
a
a
a
a
care? In M. Colleen, M. Stabile & C. Hughes Tuohy (Eds.), Exploring Social Insurance Can a Dose of Europe Cure Canadian Health Care Finance (pp. 139).
Schut, F.T. (2008). Welke toekomst voor de AWBZ? Mejudice, 1, 1-2.
Canada: School of Policy Studies. Stam, P.J.A. (2008). Risicovereveningsmodellen voor zorgverzekeringen. Ven, W.P.M.M. van de (2008). Health system reform: a perpetual emotion.
TSG, 86(1).
In B. Rosen, R. Saltman & M. Shani (Eds.), Health Systems: Are We in a Post Reform Era? (pp. 215). Nava Moscko.
Stam, P.J.A. & Ven, W.P.M.M. van de (2008). De harde kern in de risicoverevening. Economisch Statistische Berichten, 93(4529), 104-107.
Westert, G.P., Berg, M.J, van den, Koolman, A.H.E. & Verkleij, H. (2008). Zorgbalans 2008. Houten: Bohn Stafleu van Loghum.
Stam, P.J.A. & Ven, W.P.M.M. van de (2008). Evaluatie risicoverevening tussen zorgverzekeraars. TSG, 86(2), 92-100.
Article in Dutch journal
Varkevisser, M. & Schut, F.T. (2008). NMa moet strenger zijn bij toetsen ziekenhuisfusies. Economisch Statistische Berichten, 93(4532), 196-199.
Buijsen, M.A.J.M. (2008). Het nieuwe zorgstelsel en het recht op gezondheid. NJCM Bulletin. Nederlands Tijdschrift voor de Mensenrechten, 13, 1-19.
Varkevisser, M. & Schut, F.T. (2008). Reactie op: Consumentenbelang gaat boven concurrentenbelang. Economisch Statistische Berichten, (4534), 285.
Exter, A.P. den (2008). Het biogeneeskundeverdrag en de relevantie voor Nederland. Zorg & Financiering, 9, 1168-1169.
Vlems, F.A., Stam, P.J.A. & Poll, A. (2008). Zorginkoop en de CQ-index. TSG, 86(8), 426-427.
Geest, S.A. van der & Varkevisser, M. (2008). Kwaliteitsinformatie en de marktaandelen van IVF-centra. Economisch Statistische Berichten, 756-758.
Wehrens, R.L.E., Bekker, M.P.M., Egmond, C. van, Putters, K. & Bal, R. (2008). De Academische Werkplaats als grensorganisatie. De coördinatie van
Grit, K.J., Bovenkamp, H.M. van de & Bal, R. (2008). De positie van de
onderzoek, praktijk en beleid in de Academische Werkplaatsen. TSG, 86(6), 1-8.
zorggebruiker in een veranderend stelsel. Rotterdam: instituut Beleid & Management Gezondheidszorg.
Research line: Quality and efficiency in health care Hermans, H.E.G.M. (2008). Fusies tussen zorginstellingen de gebeten hond nogmaals geslagen. ZorgInstellingen, 33, 1-1.
Article/Letter to the editor
Hermans, H.E.G.M. (2008). Het Amphia-arrest van de Hoge Raad Betekent dit
Al, M.J., Maniadakis, N., Grijseels, E.W.M. & Janssen, M. (2008). Costs and
het einde Europees aanbesteden? ZM Magazine, 1, 10-13.
effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands. Value in Health, 11(4), 589-599.
Hermans, H.E.G.M. (2008). Nieuwe Europese verordeningen en richtlijnen. Zorg & Financiering, 3, 15-24.
Attema, A.E. & Brouwer, W.B.F. (2008). Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement. Health Economics, 17,
Hermans, H.E.G.M. & Scholten, G.R.M. (2008). Raden van toezicht bij zorg-
877-885.
instellingen: een doorgeschoten fenomeen. Zorg & Financiering, 6, 10-24. Bago d'Uva, T., O'Donnell, O. & Doorslaer, E.K.A. van (2008). Differential health Hermans, H.E.G.M. (2008). Wat mij opvalt… Aandelen in het ziekenhuis.
reporting by education level and it's impact on the measurement of health
Zorg & Financiering, 3, 191-191.
inequalities among older Europeans. International Journal of Epidemiology, 37, 1375-1383.
Hermans, H.E.G.M. (2008). Wat mij opvalt… Invallen NMa en NZa. Zorg & Financiering, 7, 1-1.
39
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Bago d'Uva, T., Doorslaer, E.K.A. van, Lindeboom, M. & O'Donnell, O. (2008).
related absence from work in women and the contribution of general and
Does reporting heterogeneity bias the measurement of health disparities.
emotional factors. Acta Obstetricia et Gynecologica Scandinavica, 87, 1169-1175.
Health Economics, 17 (3), 351-375. Breekveldt-Postma, N.S., Koerselman, J., Erkens, J.A., Molen, T. van der, Baal, P.H.M., Polder, J.J., Wit, G.A. de, Hoogeveen, R.T., Feenstra, T.L., Boshuizen,
Lammers, J.W.J. & Herings, R.M.C. (2008). Treatment with inhaled cortico-
H.C., Engelfriet, P.M. & Brouwer, W.B.F. (2008). Lifetime medical costs of obesity:
steroids in asthma is too often discontinued. Pharmacoepidemiology and Drug
prevention no cure for increasing health expenditure. PLoS Medicine, 5(2),
Safety, 17, 411-422.
242-249. Brouwer, W.B.F. (2008) Perspective, costs, outcomes and discounting in Berg, B. van den, Al, M.J., Exel, N.J.A. van, Koopmanschap, M.A. & Brouwer,
economic evaluations. European Journal of Hospital Pharmacy 14(3), 20-22.
W.B.F. (2008). Economic valuation of informal care: conjoint analysis applied in a heterogeneous population of informal caregivers. Value in Health, 11(7),
Brouwer, W.B.F., Exel, N.J.A. van, Baker, R., Donaldson, C. (2008)The new myth:
1041-1050.
The social value of the QALY. PharmacoEconomics, 26(1),1-4.
Boormans, E.M., Birnie, E., Wildschut, H.I.J., Schuring-Blom, G.H., Oepkes, D.,
Brouwer, W.B.F., Culyer, A.J., Exel, N.J.A. van & Rutten, F.F.H. (2008). Welfarism
Oppen, A.C. van, Nijhuis, J.G., Macville, M., Go, A., Creemers, J. , Bhola, S.L.,
vs. extra-welfarism. Journal of Health Economics, 27, 325-338.
Bilardo, C.M., Suijkerbuijk, R., Bouman, K., Galjaard, R.J.H., Bonsel, G.J. & Lith, J.M. van (2008). Multiplex ligation-dependent probe amplification versus
Buijsen, M.A.J.M. (2008). Biolaw in the Netherlands: Recent Developments.
karotyping in prenatal diagnosis: the M.A.K.E. study. BMC Pregnancy and
Diritto Pubblico Comparato Ed Europeo, 1685(1699), 4.
Childbirth, 8, 18. Buijsen, M.A.J.M. (2008). Werktitel: reactie op Craig Peterson. Medicine, Health Bleichrodt, H., Rohde, K.I.M. & Wakker P.P. (2008). Koopmans' Constant
Care and Philosophy, 489-494.
Discounting: A Simplification and an Extension to Incorporate Technological Progress. Journal of Mathematical Psychology 52, 341-347.
Cazzola, M., MacNee, W., Martinez, F.J., Rabe, K.F., Franciosi, L.G., Barnes, P.J., Brusasco, V., Miravitlles, M., Page, C.P., Palange, P., Parr, D., Pistolesi, M.,
Bleichrodt, H., Crainich, D., & Eeckhoudt, L. (2008). Aversion to Health
Rennard, S.I., Stockley, R., Sullivan, S.D., Wedzicha, J.A., Wouters, E.F.M. &
Inequalities and Priority Setting in Health Care. Journal of Health Economics 27,
Rutten-van Mölken, M.P.M.H. (2008). Outcomes for COPD pharmacological
1594-1604.
trials: from lung function to biomarkers. European Respiratory Journal, 31(2), 416-468.
Bleichrodt, H., Rohde, K.I.M. & Wakker, P.P. (2008). Combining Additive Representations on Subsets into an Overall Representation. Journal of
Christiaans, I., Birnie, E., Bonsel, G.J., Wilde, A.A.M. & Langen, I.M. van (2008).
Mathematical Psychology 52, 304-310.
Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. European Journal of Human Genetics, 16, 1201-1207.
Bleichrodt, H. & Filko, M. (2008). New and Robust Tests of QALYs when Health Varies over Time. Journal of Health Economics 27, 1237-1249.
Cohen, J.P., Stolk, E.A. & Niezen, M.G.H. (2008). Role of Budget Impact in Drug Reimbursement Decisions. Journal of Health Politics, Policy and Law, 33(2),
Boormans, E.M.A., Birnie, E., Wildschut, H.I.J., Schuring-Blom, G.H., Oepkes, D.,
225-247.
Oppen, A.C. van, Nijhuis, J.G., Macville, M.V.E., Kooper, A.J.A., Huijsdens, K.,
40
Hoffer, M.V.J. , Go, A., Creemers, J., Bhola, S.L., Bilardo, K.M., Suijkerbuijk, R.,
Delhaas, E.M., Beersen, N., Redekop, W.K. & Klazinga, N.S. (2008) Long-term
Bouman, K., Galjaard, R.J.H., Bonsel, G.J. & Lith, J.M.M. van (2008).
outcomes of continuous intrathecal baclofen infusion for treatment of spasticity:
BMC Pregnancy and Childbirth. BioMed Central, 8(18).
a prospective multicenter follow-up study. Neuromodulation, 11, 227-236.
Bouwmans, C.A.M., Lintsen, B.M.E., Eijkemans, M.J.C., Habbema, J.D.F. & Braat,
Doorslaer, E.K.A. van, Clarke, P., Savage, E. & Hall, J. (2008). Horizontal inequities
D.D.M. (2008). A detailed cost analysis of in vitro fertilization and
in Australia's mixed public/private health care system. Health Policy, 86 (1),
intracytoplasmic sperm injection treatment. Fertility & Sterility, 89(2), 331-341.
97-108.
Bouwmans, C.A.M., Lintsen, A.M.E., Al, M.J., Verhaak, C.M., Eijkemans, M.J.C.,
Eijsden, M. van, Smits, L.J.M., Wal, M.F. & Bonsel, G.J. (2008). Association
Habbema, J.D.F., Braat, D.D.M. & Hakkaart-van Roijen, L. (2008). Absence from
between short interpregnancy intervals and term birth weight: the role of
work and emotional stress in woman undergoing IVF or ICSI: An analysis of IVF-
folate depletion. American Journal of Clinical Nutrition, 88, 147-153.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Eijsden, M. van, Hornstra, G., Wal, M.F., Vrijkotte, T.G.M. & Bonsel, G.J. (2008).
Goossens, L.M.A., Standaert, B., Hartwig, N.G., Hovels, A.M. & Al, M.J. (2008).
Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth
The cost-utility of rotavirus vaccination with Rotarix TM (RIX4414) in the
weight: a prospective cohort study 1-3. American Journal of Clinical Nutrition,
Netherlands. Vaccine, 26, 1118-1127.
a
a
a
a
a
a
a
a
a
87, 887-895. Groenendijk, A.G., Birnie, E., Boeckxstaens, G.E., Roovers, J.P.W & Bonsel, G.J. Exel, N.J.A. van, Graaf, G. de & Brouwer, W.B.F. (2008). Give me a break!
(2008). Anorectal function testing and anal endosonography in the diagnostic
Informal caregiver attitudes towards respite care. Health Policy, 88, 73-87.
work-up of patients with primary pelvic organ prolapse. Gynecologic & Obstetric Investigation, 187-194.
Exel, N.J.A. van, Bobinac, A., Koopmanschap, M.A. & Brouwer, W.B.F. (2008). The invisible hands made visible: Recognizing the value of informal care in
Groenendijk, A.G., Hulst, V.P., Birnie, E. & Bonsel, G.J. (2008). Correlation
health care decision making. Expert Review of PharmacoEconomics and
between posterior vaginal wall defects assessed by clinical examination and by
Outcomes Research,8(6), 557-561.
defecography. International Urogynecology Journal and Pelvic Floor Dysfunction, 19, 1291-1297.
Exel, N.J.A. van, Ruiter, M. de & Brouwer, W.B.F. (2008). When time is not on your side. Patient experiences with waiting for home care and admission to a nursing or residential home. Patient 2008, 1(1), 55-71.
Fakiri, F., Bruijnzeels, M.A., Foets, M.M.E. & Hoes, A.W. (2008). Different distribution of cardiovascular risk factors according to ethnicity: a study in a high risk population. Journal of Immigrant and Minority Health, 10, 559-565.
Feenstra, T.L., Baal van P.H.M., Gandjour, A. & Brouwer, W.B.F. (2008). The inclusion of future medical costs in economic evaluations. A comment on Lee. Journal of Health Economics, 27(6), 1645-1649.
Flores, G., Krishnakumar, J., O'Donnell, O. & Doorslaer, E.K.A. van (2008). Coping with health-care costs: implications for the measurement of catastrophic expenditures and poverty. Health Economics, 17, 1393-1412.
Galani, C.M. & Rutten, F.F.H. (2008). Self-reported healthcare decision-makers' attitudes towards economic evaluations of medical technologies. Current Medical Research & Opinion, 24, 3049-3058.
Galani, C.M., Al, M.J., Schneider, H. & Rutten, F.F.H. (2008). Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people. Value in Health, 11(3), 424-434.
Gischler, S.J., Mazer, P., Poley, J.W., Tibboel, D. & Dijk, M. van (2008). Telephone helpline for parents of children with congenital anomalies. Journal of Advanced Nursing, 64(6), 625-631.
Haagsma, J.A., Beeck, E.F. van, Polinder, S., Hoeymans, N., Mulder, S. & Bonsel, G.J. (2008). Novel empirical disability weights to assess the burden of non-fatal
Goedhart, G., Eijsden, M. van, Wal, M.F. & Bonsel, G.J. (2008). Ethnic differences
injury. Injury Prevention, 14, 5-10.
in preterm birth and its subtypes: the effect of a cumulative risk profile. BJOG An International Journal of Obstetrics and Gynaecology, 115, 710-719.
Hanley, G.E., Morgan, S., Hurley, J. & Doorslaer, E.K.A. van (2008). Distributional consequences of the transition from age-based to income-based prescription
Goedhart, G., Eijsden, M. van, Wal, M.F. & Bonsel, G.J. (2008). Ethnic differences
drug coverage in British Colombia, Canada. Health Economics, 17, 1379-1392.
in term birthweight: the role of constitutional and environmental factors. Paediatric and Perinatal Epidemiology, 22, 360-368.
41
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Heijink, R., Noethen, M., Bohnen, A.M., Koopmanschap, M.A. & Polder, J. (2008).
Janssen, M.F., Birnie, E. & Bonsel, G.J. (2008). Quantification of the level
Cost of illness: an international comparison Australia, Canada, France, Germany
descriptors for the standard EQ-5D three-level system and a five-level version
and The Netherlands. Health Policy, 88(1):49-61.
according to two methods. Quality of Life Research, 17, 463-473.
Heijink, R., Koolman, A.H.E., Pieter, D., Veen, A. van der, Jarman, B. & Westert,
Jimenez-Rubio, D., Smith, C. & Doorslaer, E.K.A. van (2008). Equity in health and
G.P. (2008). Measuring and explaining mortality in Dutch hospitals; the
health care in a decentralised context: evidence from Canada. Health
hospital standardized mortality rate between 2003 and 2005. BMC Health
Economics, 17(3), 377-392.
Services Research, 8(73), 1-8. Kerremans, J.J., Verboom, P., Stijnen, T., Hakkaart-van Roijen, L., Goessens, W., Hoogendoorn, M., Welsing, P. & Rutten-van Mölken, M.P.M.H. (2008). Cost-
Verbrugh, H.A. & Vos, M.C. (2008). Rapid identification and antimicrobial
effectiveness of vareniclin compared with bupropion, NRT and nortriptyline for
susceptibility testing reduce antibiotic use and accelerate pathogen-directed
smoking cessation in the Netherlands. Current Medical Research & Opinion,
antibiotic use. Journal of Antimicrobial Chemotherapy, 61(2),428-35.
24(1), 51-61. Koelewijn, J.M., Vrijkotte, T.G.M., Schoot, C.E. van der, Bonsel, G.J. & Haas, M. de Janssen, M.F., Birnie, E., Haagsma, J.A. & Bonsel, G.J. (2008). Comparing the
(2008). Effect of screening for red cell antibodies, other than anti-D, to detect
standard EQ-5D Three level system with a five level version. Value in Health,
hemolytic disease of the fetus and newborn: a population study in the
11(2), 275-284.
Netherlands. Transfusion, 48, 941-952.
Janssen, M.F., Birnie, E. & Bonsel, G.J. (2008). Feasibility and reliability of the
Koelewijn, J.M., Haas, M. de, Vrijkotte, T.G.M., Bonsel, G.J. & Schoot, C.E. van der
annual profile method for deriving qualy's for short-term health conditions.
(2008). One single dose of 200 ug of antenatal RhIG halves the risk of anti-D
Medical Decision Making, 28, 500-510.
immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion, 48, 1721-1729.
Koopmanschap, M.A., Exel, N.J.A. van, Berg, B. van den & Brouwer, W.B.F. (2008). An overview of methods and applications to value informal care in economic evaluations of healthcare. PharmacoEconomics, 26(4), 269-280.
Kreuger, L., Exel, N.J.A. van & Nieboer, A.P. (2008). Needs of persons with severe intellectual disabilities: a q-methodological study of clients with severe behavioural disorders and severe intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 21, 466-476.
Lamers, J.M., Stupp, R., Bent, M.J. van den, Al, M.J., Gorlia, T., Wasserfallen, J.B., Mittmann, N., Seung, S.J., Crott, R. & Uyl-de Groot, C.A. (2008). Costeffectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme. Cancer, 112(6), 1337-1344.
Lamkaddem, M., Spreeuwenberg, P.M., Deville, W.J.L.M., Foets, M.M.E. & Groenewegen, P.P. (2008). Changes in health and primary health care use of Moroccan and Turkish migrants between 2001 and 2005: a longitudinal study. BMC Public Health, 8(40), 1-8.
Meheus, F., Doorslaer, E.K.A van (2008). Socio-economic differences in measles immunization: evidence from Demographic and Health Surveys, Social Science & Medicine, 2008, 66(8): 1709-18.
O'Donnell, O., Doorslaer, E.K.A. van, Rannan-Eliya, R.P., Somanathan, A. , Adhikari, S.R., Akkazieva, B., Harbianto, D., Garg, C.C., Hanvoravongchai, P., Herrin, A.N., Huq, M.N., Ibragimova, S., Karan, A., Kwon, S.M., Leung, G.M., Lu,
42
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
J.F.R., Ohkusa, Y., Pande, B.R., Racelis, R., Tin, K., Tisayaticom, K., Trisnantoro, L.,
Tan, S.S., Hakkaart-van Roijen L., Al, M.J., Bouwmans C.A.M., Hoogendoorn
Wan, Q., Yang, B.M. & Zhao, Y. (2008). Who pays for health care in Asia? Journal
M.E., Spronk P.E., Bakker J.A. (2008) Microcosting study of intensive care unit
of Health Economics, 27 (2), 460-475.
stay in the Netherlands. Journal of Intensive Care Medicine, 23, 250-257.
Nijdam, W., Levendag, P.C., Noever, I., Schmitz, P.I.M. & Uyl-de Groot, C.A.
Valentine, N., Darby, C. & Bonsel, G.J. (2008). Which aspects of non-clinical
(2008). Longitudinal changes in quality of life and costs in long-term survivors
quality of care are most important? Results from WHO's general population
of tumors of the oropharynx treated with brachytherapy or surgery.
surveys of: "health systems responsiveness" in 41 countries. Social Science &
Brachytherapy, 7, 343-350.
Medicine, 66, 1939-1950.
Oostenbrink, J.B., Al, M.J., Oppe, M. & Rutten-van Mölken, M.P.M.H. (2008).
Volkers, N.A., Hehenkamp, W.J.K., Spijkerboer, A.M., Moolhuijzen, A.D., Birnie,
Expected value of perfect information: An Empirical example of reducing
E., Ankum, W.M. & Reekers, J.A. (2008). MR Reproducibility in the assessment of
decision uncertainty by conducting additional research. Value in Health, 11,
uterine fibroids for patients scheduled for uterine artery embolization.
1070-1080.
Cardiovascular & Interventional Radiology, 260-268.
Poleij, M.J., Brouwer, W.B.F., Busschbach, J.J.V. van, Hazebroek, F.W.J., Tibboel, D.,
Wetering, C.R. van, Nooten, F.E. van, Mol, S.J.M., Hoogendoorn, M., Rutten-van
Rutten, F.F.H. & Molenaar, J.C. (2008). Cost-effectiveness of neonatal surgery:
Mölken, M.P.M.H. & Schols, A.M.W.J. (2008). Systemic impairment in relation to
first greeted with scepticism, now increasingly accepted. Pediatric Surgery
disease burden in patients with moderate COPD eligble for a lifestyle program.
International, 24(2), 119-127.
Findings from the INTERCOM trial. International Journal of COPD, 3(3), 443-451.
a
a
a
a
a
a
a
Rappange, D.R., Baal, P.H.M., Exel, N.J.A. van, Feenstra, T.L., Rutten, F.F.H. & Brouwer, W.B.F. (2008). Unrelated medical costs in life-years gained should they
Book (chapter)
be included in economic evaluations of healthcare interventions? PharmacoEconomics, 26(10), 815-860.
Brouwer, W.B.F., Rutten, F.F.H. (2008) The Netherlands. In J. Rapoport, J.P. Jacobs, E. Jonsson (Eds.), Cost Containment and Efficiency in National Health Systems:
Redekop, W.K., Orlewska, E., Maciejewski, P., Rutten, F.F.H. & Niessen, L.W.
A Global Comparison. Weinheim: Wiley-Blackwell.
(2008). Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland. PharmacoEconomics, 26, 861-877.
Buijsen, M.A.J.M. (2008). Thomas van Aquino. Over de wet. Zoetermeer: Uitgeverij Meinema.
Rep, A., Ganzevoort, W., Wassenaer, A.G., Bonsel, G.J., Wolf, H. & Vries, J.I.P. (2008). One-year infant outcome in women with early-onset hypertensive
Koolman, A.H.E. (2008). Hoe toegankelijk is de gezondheidszorg? In G.P.
disorders of pregnancy. Epidemiology, 15, 290-298.
Westert, M.J. van den Berg, A.H.E Koolman & H. Verkleij (Eds.), Zorgbalans (pp. 3.1-3). Houten: Bohn Stafleu Van Loghum.
Rutten, F.F.H. & Vulto, A.G. (2008). Pharmacoeconomics: science, practice and challenges. European Journal of Hospital Pharmacy Practice, 14, 16.
Koolman, A.H.E. (2008). Hoeveel kost de gezondheidszorg? In G.P. Westert, M.J. van den Berg, A.H.E Koolman & H. Verkleij (Eds.), Zorgbalans 2008 (pp. 4.1-4).
Scalone, L., Mantovani, L.G., Krol, H.M., Rofail, D., Ravera, S., Garretsen, H.F.L.,
Houten: Bohn Stafleu Van Loghum.
Borgna-Pignatti, C., Borsellino, L., Cianciulli, P., Bonsel, G.J., Prossomariti, L., Stefano, I. & Cappellini, M.D. (2008). Costs, quality of life, treatment
Koolman, A.H.E. (2008). Het oordeel van burgers en zorggebruikers over de
satisfaction and compliance in patients with B-thalassemia major undergoing
gezondheidszorg. In G.P. Westert, M.J. van den Berg, A.H.E Koolman & H. Verkleij
iron chelation therapy: the ITHACA study. Current Medical Research & Opinion,
(Eds.), Zorgbalans 2008 (pp. 5.2-5). Houten: Bohn Stafleu Van Loghum.
24(7), 1905-1917. Leu, R.E., Rutten, F.F.H., Brouwer, W.B.F., Rutschi, C. & Matter, P. (2008). The Sczepura, A., Bonsel, G.J., Krauth, C. , Osipenko, L. & Haverkamp, A. (2008). Is
Swiss and the Dutch health care systems compared. Baden Baden: Nomos.
fetal RHD typing in all RHD negative women cost effective? BMJ, 336, 905-906.
Tan, S.S., Redekop, W.K. & Rutten, F.F.H. (2008). Costs and prices of single dental
Article in Dutch journal
fillings in Europe: a micro-costing study. Health Economics, 83-93. Attema, A.E. (2008). De rol van tijdsvoorkeur bij de waardering van gezondheid. TPEdigitaal, 2(4), 92-105.
43
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Baal, P.H.M., Brouwer, W.B.F., Wit, G.A. de, Hoogeveen, R.T. & Polder, J.J. (2008).
Polder, J. & Brouwer, W.B.F. (2008). Tien woorden gezondheidseconomie. 4.
De invloed van roken en overgewicht op zorguitgaven. TSG, 86(3), 150-155.
Rechtvaardige verdeling: het verhaal van Bart, Werner, Johan en Kees. TSG, 63-68.
Bont, A.A. de, Wallenburg, I., Heineman, M.J., Luijk, S.J., Diemen-Steenvoorde,
Reeuwijk-Werkhorst, J. van & Hulst, E.H. (2008). Ketenzorg eist heldere
J.A.A.M., Scheele, F. & Meurs, P.L. (2008). Onderwijsvernieuwing als beleids-
afspraken. Zorg & Financiering, 4, 10-23.
instrument. Over de modernisering van de medische vervolgopleidingen. Tijdschrift voor Medisch Onderwijs, 27(6), 316-322.
Research line: Health care management Brouwer, W.B.F., Exel, N.J.A. van & Baal, P. (2008). Kosten in de gewonnen levensjaren niet langer negeren! TSG, 86(1), 1-1.
Article/Letter to the editor
Buijsen, M.A.J.M. (2008). Autonomie, waardigheid en het recht op gezond-
Batenburg, R., Versendaal, J. & Breedveld, E.J. (2008). Exploring IT opportunities:
heidszorg in vraagstukken rondom het levenseinde. Pro Vita Humana, 15(3),
the case of the Dutch elderly policy chain. Journal of Cases on Information
70-75.
Technology, 10(3), 65-76.
Buijsen, M.A.J.M. (2008). De geneeskundige behandelrelatie: wezenlijk uniek.
Bont, A.A. de & Bal, R. (2008). Conflicting perceptions of an inter-disciplinary
TGE. Tijdschrift voor Gezondheidszorg & Ethiek, 18(3), 83-88.
telemedicine project. How a successful project failed. BMC Medical Informatics and Decision Making, 8(47), 1-8.
Buijsen, M.A.J.M. (2008). Goed patiëntschap volgens de RVZ. Een slecht idee. Tijdschrift voor Gezondheidsrecht, 32(5), 328-337.
Cornielje, H., Velema, J.P. & Finkenflügel, H.J.M. (2008). Community based rehabilitation programmes: monitoring and evaluation in order to measure
Buijsen, M.A.J.M. (2008). Het recht op zorg is een mensenrecht – Hoe staats-
results. Leprosy Review, 79, 36-49.
paternalisme leidt tot discriminatie. Socialisme en Democratie, 65(5), 14-19. Cramm, J.M., Tebra, N. & Finkenflügel, H.J.M. (2008). Colleagues' perception of Buijsen, M.A.J.M. (2008). Orgaandonatie & menselijke waardigheid.
supported employee performance. Journal of Policy and Practice in Intellectual
Pro Vita Humana, 15(2), 29-36.
Disabilities, 5(4), 269-275.
Buijsen, M.A.J.M. (2008). Orgaandonatie: kies voor solidariteit. Socialisme en
Cramm, J.M. & Finkenflügel, H.J.M. (2008). Exclusion of disabled people from
Democratie, 65(11), 5-6.
microcredit in Africa and Asia: A literature study. Asia Pacific Disability Rehabilitation Journal, 19(2), 15-33.
Buijsen, M.A.J.M. (2008). RVZ-plan ondoordacht. Medisch Contact, 63(17), 730-732. Duijm, L.E.M., Groenewoud, J.H., Fracheboud, J., Plaisier, M.L., Roumen, R.M.H., Buijsen, M.A.J.M. (2008). Wanprestatie en opzegging in de hulpverlening.
Ineveld, B.M. van, Beek, M. van & Koning, H.J. de (2008). Utilization and cost of
Journaal Privacy Gezondheidszorg, 9(5), 111-115.
diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands 2000-2005.
Duin, T van der, Jerak, S. & Bal, R. (2008). Verleng triagetijd spoedzorgmelding
European Radiology, 18, 2390-2397.
naar drie minuten. Ambulancezorg, 4, 30-35. Finkenflügel, H.J.M. & Rule, S. (2008). Integrating community-based Hulst, E.H. (2008). Mogen we nog wegen bouwen? Een beschouwing naar
rehabilitation and leprosy rehabilitation services into an inclusive development
aanleiding van de A4-uitspraak. Tijdschrift voor Milieuschade en
approach. Leprosy Review, 79, 83-91.
Aansprakelijkheidsrecht, 22(2), 23-36. Finkenflügel, H.J.M., Cornielje, H. & Velema, J.P. (2008). The use of classification
44
Hulst, E.H. (2008). Orgaandonatie: geen bezwaart tegen 'geen bezwaar'.
models in the evaluation of CBR programmes. Disability & Rehabilitation, 30(5),
Nederlands Juristenblad (NJB), 29, 1796-1799.
348-354.
Mulder, H., Luijk, S.J., Busari, J.O., Schutte, M.F., Vreede, I. de, Scheele, F., Bont,
Glind, I.M. van de, Dulmen, A.M. & Goossensen, M.A. (2008). Physician-patient
A.A. de, Wallenburg, I. & Diemen-Steenvoorde, J.A.A.M. (2008). In VIVO
communication in single-bedded versus four-bedded hospital rooms. Patient
anderhalf jaar onderweg! Tijdschrift voor Medisch Onderwijs, 27(6), 304-309.
Education and Counseling, 73, 215-219.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Groenewoud, A.S., Exel, N.J.A. van, Berg, M. & Huijsman, R. (2008). Building
Minkman, M., Ahaus, K., Fabbricotti, I.N., Nabitz, U. & Huijsman, R. (2008). A
quality report cards for geriatric care in the Netherlands: using concept
quality management model for integrated care: results of a Delphi and Concept
mapping to identify the appropriate 'Building Blocks' from the consumer's
Mapping study. International Journal for Quality in Health Care, 20, 1-10.
a
a
a
a
a
a
a
perspective. Gerontologist, The, 48(1), 79-92. Niazkhani, Z., Pirnejad, H., Bont, A.A. de & Aarts, J.E.C.M. (2008). Evaluating Korne, D.F. de, Hiddema, U.F., Bleeker, F.G. & Klazinga, N.S. (2008). Flying with
inter-professional work support by a computerized physician order entry
doctors: experiences with the application of 6 techniques from aviation
(CPOE) system. Studies in Health Technology and Informatics, 136, 321-326.
industry in the Rotterdam Eye Hospital. Time out Intensiva: il tempo e la memoria in terapia intensiva, 7, 1-5.
Niazkhani, Z. (2008). Evaluating the Impact of CPOE Systems on Medical Workflow: a Mixed Method Study. Studies in Health Technology and Informatics, 136, 881-882.
Pirnejad, H., Bal, R. & Berg, M. (2008). Building an inter-organizational communication network and challenges for preserving interoperability. International Journal of Medical Informatics, 77, 818-827.
Pirnejad, H., Niazkhani, Z., Sijs, H. van der, Berg, M. & Bal, R. (2008). Impact of a computerized physician order entry system on nurse-physician collaboration in the medication process. International Journal of Medical Informatics, 77, 735-744.
Pirnejad, H., Niazkhani, Z., Berg, M. & Bal, R. (2008). Intra-organizational communication in healthcare considerations for standardization and ICT application. Methods of Information in Medicine, 47, 336-345.
Schouten, L.M.T., Hulscher, M.E.J.L., Everdingen, J.J.E. van, Huijsman, R. & Grol, R.P.T.M. (2008). Evidence for the impact of quality improvement collaboratives: systematic review. BMJ, 1491-1494.
Schouten, L.M.T., Hulscher, M.E.J.L., Akkermans, R., Everdingen, J.J.E. van, Grol, R.P.T.M. & Huijsman, R. (2008). Factors that influence the stroke care team's effectiveness in reducing the length of hospital stay. Journal of the American Heart Association, 39, 2515-2521.
Schouten, L.M.T., Hulscher, M.E.J.L., Akkermans, R., Everdingen, J.J.E. van, Grol, R.P.T.M. & Huijsman, R. (2008). Factors that influence the stroke care team’s effectiveness in reducing the length of hospital stay. Stroke, 2515-2521. Lemmens, K.M.M., Nieboer, A.P., Schayck, C.P. van, Asin, J.D. & Huijsman, R. (2008). A model to evaluate quality and effectiveness of disease management.
Schreiner, N.A.F.M. (2008). Wat wil ik nu eigenlijk? Iedere jongere zijn eigen
Quality & Safety in Health Care, 17, 447-453.
loopbaancoach. Gids voor Personeelsmanagement, 87(12), 34-37.
Lemmens, K.M.M., Nieboer, A.P. & Huijsman, R. (2008). Designing patient-
Schreiner, N.A.F.M. (2008). Wie carrière maakt mag het zeggen. Loopbaan-
related interventions in COPD care: Empirical test of a theoretical model.
concepten in subjectief perspectief. Develop, 4, 8-19.
Patient Education and Counseling, 72, 223-231. Sijs, H. van der & Aarts, J. et al. (2008). Turning off frequently overridden drug Lusignan, S. de, Aarts, J. (2008). UK's National Programme for IT welcomes
alerts: limited opportunities for doing it safely. JAMIA Journal of the American
recommendation for a more sociotechnical approach to evaluation: a
Medical Informatics Association 15(4), 439-48.
commentary on the Greenhalgh evaluation of the summary care record. Inform Prim Care 16(2), 75-7.
45
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Staa, A.L. van, Jedeloo, S., Latour, J.M. & Trappenburg, M.J. (2008). A normal life
Duin, T. van der, Jerak, S. & Bal, R. (2008). Twee minuten norm telefonische
with an unhealthy body: self-identity in adolescents growing up with chronic
triage beïnvloedt kwaliteit ook negatief. Ambulancezorg, 5(4), 30-35.
a
a
illness. Pediatrics, 121, S103. Goossensen, M.A. (2008). Veranderen en vernieuwen in de verslavingszorg (4): Staa, A.L. van, Latour, J.M. & Exel, J. van (2008). Using Q-methodology to
over 'social movements'. Verslaving, 4(2), 70-72.
explore preferences for care of adolescents with chronic disorders: 4 profiles. Pediatrics, 121, S154-S155.
Goossensen, M.A. (2008). Veranderen en vernieuwen in de verslavingszorg (5): over projectleiders en diepgaand zelfonderzoek. Verslaving, 4(3), 54-56.
Tielen, M., Staa, A.L. van, Jedeloo, S., Exel, N.J.A. van & Weimar, W. (2008). Q-methodology to indentify young adult renal transplant recipients at risk for
Huijsman, R. (2008). Begin met inhoud niet met geld. ZorgVisie (Maarssen),
nonadherence. Transplantation, 85(5), 700-706.
6a, 1-1.
Kuijsten, W.C., Cramm, J.M., Exel, N.J.A. van & Finkenflügel, H.J.M. (2008).
Book (chapter)
Werkt werken? Onderzoek naar de mening van mensen met een verstandelijke beperking over de bijdrage van individueel begeleid werken aan hun sociale
Aarts, J. & Magrabi, F. (2008) Medical informatics and patient safety. Croskerry,
integratie. NTZ Nederlands Tijdschrift voor de Zorg, 1, 34-46.
P., Cosby, K.S., Schenkel, S.M., Wears, R.L., (Eds.), Lippincott, Williams & Wilkins, Philadelphia (pp. 111-118).
Meurs, P.L. (2008). Het 1e niveau van leidinggeven. ZM Magazine, 6, 7-7.
Staa, A.L. van, Stege, H.A. van der & Jedeloo, S. (2008). Op eigen benen verder.
Pijpers, V.C., Finkenflügel, H.J.M. & Huijsman, R. (2008). De wetenschappelijke
Jongeren met chronische aandoeningen op weg naar zelfstandigheid in de
onderbouwing van Supported Living in de verstandelijk gehandicaptenzorg:
zorg. In Op eigen benen verder. Rotterdam: Hogeschool Rotterdam.
overzicht van de literatuur. NTZ Nederlands Tijdschrift voor de Zorg, 34(4), 234-249.
Staa, A.L. van & Steultjens, E. (2008). Systematische Reviews. In Evidence-based practice voor paramedici. Methodiek en Implementatie (pp. 175-193). Utrecht:
Scheer, W. van der (2008). Legitiem Leiderschap. Zorg Executives 3(8), pp 8-13.
Lemma. Staa, A.L. van, Jedeloo, S., Latour, J.M., Stege, H.A. van der, Krones, V. & Janssen, Staa, A.L. van & Steultjens, E. (2008) Systematische Reviews. In K. Cox, D. de
I. (2008). Jongeren met chronische aandoeningen op de polikliniek: van
Louw, J. Verhoef & C.H.Z. Kuiper. Evidence-based practice voor verpleeg-
toeschouwer naar hoofdpersoon! TSG, 86(2), 49-49.
kundigen. Methodiek en implementatie. 2e herziene druk. Utrecht: Uitgeverij Lemma, 175-193.
Staa, A.L. van & Huijzen, S. van (2008). Transitie in zorg bij anusatresie/carm: aan de overgang van kinder- naar volwassenenzorg valt nog veel te verbeteren.
Steultjens E. & Staa, A.L. van (2008) Systematische Reviews. In C.H.Z. Kuiper, J.
ErVaring Blad van de Vereniging Anusatresie, 23(4), 7-8.
Verhoef, D. de Louw & K. Cox. Evidence-based practice voor paramedici. Methodiek en implementatie. 2e herziene druk. Utrecht: Uitgeverij Lemma, 169-187.
Staa, A.L. van, Hilberink, S.R., Eysink Smeets-van de Burgt, A.E., Stege, H.A. van der, Jedeloo, S. & Roebroeck, M.E. (2008). Transitie van kinderzorg naar
Stoopendaal, A. (2008). Zorg met Afstand. Betrokken bestuur in grootschalige
volwassenenzorg: Revalidatie in actie. Revalidata, 146, 3-10.
zorginstellingen (pp.1-226). Assen: Van Gorcum. Vries, G. de (2008). Beddenmonitoring Instrument voor efficiencyverbetering. Tielen, M., Jedeloo, S., Staa, A.L. van & Weimar, W. (2008). Immunosuppressive
Best Practices Zorg, 3, 26-32.
drugs and young adults: A difficult combination. In Weimar W., Bos M.A. & Busschbach J.J. (Eds.), Organ Transplantation: Ethical, Legal and Psychosocial Aspects.
Weggelaar-Jansen, J.W.M., Wijngaarden, J.D.H. van & Bal, R. (2008). Leren in
Towards a Common European Policy (pp. 555). Germany: Pabst Science Publishers.
een quality collaborative. Sigma, 6, 4-8.
Wijk, K.P. van (2008). De Service Care Chain. De waarde van HRM en service
46
Article in Dutch journal
voor zorgorganisaties. ZM Magazine, 2-5.
Boon, C.T. (2008). HRM en fit: hoe meer 'fit' met de organisatie, hoe beter?
Wit, F. de & Bal, R. (2008). Spiegelbijeenkomsten leveren zorgverleners nuttige
Tijdschrift voor HRM, 4, 29-44.
feedback. Medisch Contact, 63(23), 990-993.
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
47
a
a
a
a
a
a
Colophon
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
institute of Health Policy and Management Visiting address Burgemeester Oudlaan 50 3062 PA Rotterdam Postal address P.O. Box 1738 3000 DR Rotterdam The Netherlands Telephone: +31 10 408 8555 E-mail:
[email protected] Internet: www.bmg.eur.nl Final editing and production supervision Sander Bus Editors Sonja Meeuwsen, Astrid van Keulen, Yvonne Lengkeek, Werner Brouwer Translation and text revision Impact Taalburo, Rotterdam Photography Levien Willemse (except where stated otherwise) Design Ernst de Jonge Visuele Communicatie Print Veenman Drukkers, Rotterdam Copies 1000
48
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
Erasmus MC Institute of Health Policy and Management Activities Report 2007-2008
a
institute of Health Policy and Management Activities Report 2007-2008
